The	O
internal	O
methionine	O
codons	O
of	O
human	B-DNA
T-cell	I-DNA
leukemia	I-DNA
virus	I-DNA
type	I-DNA
II	I-DNA
rex	I-DNA
gene	I-DNA
are	O
not	O
required	O
for	O
p24rex	B-protein
production	O
or	O
virus	O
replication	O
and	O
transformation	O
.	O

Human	O
T-cell	O
leukemia	O
virus	O
types	O
I	O
(	O
HTLV-I	O
)	O
and	O
II	O
(	O
HTLV-II	O
)	O
have	O
two	O
nonstructural	B-DNA
trans-acting	I-DNA
regulatory	I-DNA
genes	I-DNA
,	O
tax	B-DNA
and	O
rex	B-DNA
,	O
located	O
in	O
the	O
3	B-DNA
'	I-DNA
region	I-DNA
of	O
the	O
viral	B-DNA
genome	I-DNA
.	O

The	O
tax	B-protein
gene	I-protein
product	I-protein
(	O
HTLV-I	B-protein
p40tax	I-protein
and	O
HTLV-II	B-protein
p37tax	I-protein
)	O
is	O
the	O
transcriptional	O
activator	O
of	O
the	O
viral	B-DNA
long	I-DNA
terminal	I-DNA
repeat	I-DNA
.	O

The	O
rex	B-DNA
gene	I-DNA
encodes	O
two	O
protein	O
products	O
,	O
p27rex/p21rex	B-protein
and	O
p26rex/p24rex	B-protein
in	O
HTLV-I	O
and	O
HTLV-II	O
,	O
respectively	O
.	O

Rex	B-protein
acts	O
posttranscriptionally	O
to	O
facilitate	O
accumulation	O
of	O
full-length	O
gag/pol	B-protein
and	O
singly	O
spliced	O
env	B-RNA
mRNA	I-RNA
in	O
the	O
cytoplasm	O
of	O
HTLV-infected	B-cell_type
cells	I-cell_type
.	O

Previous	O
studies	O
showed	O
that	O
the	O
first	O
ATG	O
of	O
the	O
rex	B-DNA
gene	I-DNA
is	O
critical	O
for	O
Rex	B-protein
production	O
and	O
function	O
.	O

The	O
importance	O
of	O
the	O
internal	O
ATGs	O
to	O
Rex	B-protein
function	O
is	O
not	O
known	O
.	O

However	O
,	O
in	O
vitro	O
mutagenesis	O
of	O
the	O
HTLV-I	O
rex	B-DNA
gene	I-DNA
has	O
provided	O
indirect	O
evidence	O
which	O
suggests	O
that	O
p21rex	B-protein
,	O
and	O
by	O
analogy	O
HTLV-II	O
p24rex	B-protein
,	O
results	O
from	O
initiation	O
at	O
an	O
internal	O
AUG	O
of	O
the	O
tax/rex	B-RNA
mRNA	I-RNA
.	O

By	O
using	O
an	O
infectious	O
molecular	O
clone	O
of	O
HTLV-II	O
,	O
we	O
investigated	O
the	O
importance	O
of	O
the	O
internal	O
ATGs	O
of	O
the	O
rex	B-DNA
gene	I-DNA
on	O
Rex	B-protein
protein	O
production	O
and	O
function	O
.	O

Our	O
results	O
indicate	O
that	O
p24rex	B-protein
of	O
HTLV-II	O
is	O
not	O
initiated	O
at	O
an	O
internal	O
AUG	O
and	O
that	O
the	O
internal	O
methionine	O
codons	O
are	O
not	O
crucial	O
to	O
the	O
function	O
of	O
the	O
rex	B-DNA
gene	I-DNA
and	O
,	O
ultimately	O
,	O
the	O
transforming	O
properties	O
of	O
the	O
virus	O
.	O

JoURNAL	NULL
or	NULL
ViroLOGY	NULL
,	NULL
Oct.	NULL
1990	NULL
,	NULL
p.	NULL
4914-4921	NULL
0022-538	NULL
X/90/104914-08	NULL
$	NULL
02.00/0	NULL
Copyright	NULL
©	NULL
1990	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

64	NULL
,	NULL
No	NULL
.	NULL

10	NULL
The	NULL
Internal	NULL
Methionine	NULL
Codons	NULL
of	NULL
Human	NULL
T-Cell	NULL
Leukemia	NULL
Virus	NULL
Type	NULL
II	NULL
rex	NULL
Gene	NULL
Are	NULL
Not	NULL
Required	NULL
for	NULL
p24	NULL
'	NULL
``	NULL
°*	NULL
Production	NULL
or	NULL
Virus	NULL
Replication	NULL
and	NULL
Transformation	NULL
PATRICK	NULL
L.	NULL
GREEN	NULL
,	NULL
``	NULL
YIMING	NULL
XIE	NULL
,	NULL
'	NULL
anp	NULL
IRVIN	NULL
S.	NULL
Y.	NULL
CHEN'**	NULL
Division	NULL
of	NULL
Hematology-Oncology	NULL
,	NULL
Department	NULL
of	NULL
and	NULL
Department	NULL
of	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
``	NULL
UCLA	NULL
School	NULL
of	NULL
Medicine	NULL
and	NULL
Jonsson	NULL
Comprehensive	NULL
Cancer	NULL
Center	NULL
,	NULL
Los	NULL
Angeles	NULL
,	NULL
California	NULL
90024-1736	NULL
Received	NULL
21	NULL
May	NULL
1990/Accepted	NULL
12	NULL
July	NULL
1990	NULL
Human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
types	NULL
I	NULL
(	NULL
HTLV-I	NULL
)	NULL
and	NULL
II	NULL
(	NULL
HTLV-II	NULL
)	NULL
have	NULL
two	NULL
nonstructural	NULL
trans-acting	NULL
regulatory	NULL
genes	NULL
,	NULL
tax	NULL
and	NULL
rex	NULL
,	NULL
located	NULL
in	NULL
the	NULL
3	NULL
'	NULL
region	NULL
of	NULL
the	NULL
viral	NULL
genome	NULL
.	NULL

The	NULL
tax	NULL
gene	NULL
product	NULL
(	NULL
HTLV-I	NULL
p40**	NULL
and	NULL
HTLV-II	NULL
p37	NULL
``	NULL
)	NULL
is	NULL
the	NULL
transcriptional	NULL
activator	NULL
of	NULL
the	NULL
viral	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

The	NULL
rex	NULL
gene	NULL
encodes	NULL
two	NULL
protein	NULL
products	NULL
,	NULL
p27	NULL
``	NULL
*/p21	NULL
'	NULL
``	NULL
``	NULL
*	NULL
and	NULL
p26*/p24	NULL
'	NULL
``	NULL
**	NULL
in	NULL
HTLV-I	NULL
and	NULL
HTLV-II	NULL
,	NULL
respectively	NULL
.	NULL

Rex	NULL
acts	NULL
posttranscriptionally	NULL
to	NULL
facilitate	NULL
accumulation	NULL
of	NULL
full-length	NULL
gag/po	NULL
!	NULL

and	NULL
singly	NULL
spliced	NULL
envy	NULL
mRNA	NULL
in	NULL
the	NULL
cytoplasm	NULL
of	NULL
HTLV	NULL
-infected	NULL
cells	NULL
.	NULL

Previous	NULL
studies	NULL
showed	NULL
that	NULL
the	NULL
first	NULL
ATG	NULL
of	NULL
the	NULL
rex	NULL
gene	NULL
is	NULL
critical	NULL
for	NULL
Rex	NULL
production	NULL
and	NULL
function	NULL
.	NULL

The	NULL
importance	NULL
of	NULL
the	NULL
internal	NULL
ATGs	NULL
to	NULL
Rex	NULL
function	NULL
is	NULL
not	NULL
known	NULL
.	NULL

However	NULL
,	NULL
in	NULL
vitro	NULL
mutagenesis	NULL
of	NULL
the	NULL
HTLV-I	NULL
rex	NULL
gene	NULL
has	NULL
provided	NULL
indirect	NULL
evidence	NULL
which	NULL
suggests	NULL
that	NULL
p21	NULL
``	NULL
*	NULL
,	NULL
and	NULL
by	NULL
analogy	NULL
HTLV-II	NULL
p24	NULL
'	NULL
``	NULL
*	NULL
,	NULL
results	NULL
from	NULL
initiation	NULL
at	NULL
an	NULL
internal	NULL
AUG	NULL
of	NULL
the	NULL
tfax/rex	NULL
mRNA	NULL
.	NULL

By	NULL
using	NULL
an	NULL
infectious	NULL
molecular	NULL
clone	NULL
of	NULL
HTLV-II	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
importance	NULL
of	NULL
the	NULL
internal	NULL
ATGs	NULL
of	NULL
the	NULL
rex	NULL
gene	NULL
on	NULL
Rex	NULL
protein	NULL
production	NULL
and	NULL
function	NULL
.	NULL

Our	NULL
results	NULL
indicate	NULL
that	NULL
p24'**	NULL
of	NULL
HTLV-II	NULL
is	NULL
not	NULL
initiated	NULL
at	NULL
an	NULL
internal	NULL
AUG	NULL
and	NULL
that	NULL
the	NULL
internal	NULL
methionine	NULL
codons	NULL
are	NULL
not	NULL
crucial	NULL
to	NULL
the	NULL
function	NULL
of	NULL
the	NULL
rex	NULL
gene	NULL
and	NULL
,	NULL
ultimately	NULL
,	NULL
the	NULL
transforming	NULL
properties	NULL
of	NULL
the	NULL
virus	NULL
.	NULL

Human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
types	NULL
I	NULL
(	NULL
HTLV-I	NULL
)	NULL
and	NULL
II	NULL
(	NULL
HTLV-II	NULL
)	NULL
have	NULL
been	NULL
identified	NULL
as	NULL
the	NULL
causative	NULL
agents	NULL
of	NULL
some	NULL
forms	NULL
of	NULL
leukemia	NULL
and	NULL
chronic	NULL
neurological	NULL
disorders	NULL
in	NULL
humans	NULL
.	NULL

HTLV-I	NULL
causes	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
in	NULL
a	NULL
small	NULL
percentage	NULL
of	NULL
seropositive	NULL
individuals	NULL
(	NULL
18	NULL
,	NULL
33	NULL
)	NULL
and	NULL
,	NULL
more	NULL
recently	NULL
,	NULL
has	NULL
been	NULL
linked	NULL
with	NULL
a	NULL
progressive	NULL
demyelinating	NULL
syndrome	NULL
termed	NULL
HTLV-I-associated	NULL
myelopathy	NULL
(	NULL
32	NULL
)	NULL
or	NULL
tropical	NULL
spastic	NULL
paraparesis	NULL
(	NULL
11	NULL
)	NULL
.	NULL

HTLV-II	NULL
has	NULL
been	NULL
associated	NULL
only	NULL
with	NULL
rare	NULL
forms	NULL
of	NULL
T-cell	NULL
leukemia	NULL
related	NULL
to	NULL
hairy-cell	NULL
leukemia	NULL
(	NULL
22	NULL
,	NULL
38	NULL
,	NULL
40	NULL
)	NULL
,	NULL
and	NULL
thus	NULL
its	NULL
disease	NULL
association	NULL
is	NULL
less	NULL
substantiated	NULL
.	NULL

However	NULL
,	NULL
recent	NULL
studies	NULL
revealed	NULL
that	NULL
a	NULL
significant	NULL
percentage	NULL
of	NULL
intravenous	NULL
drug	NULL
abusers	NULL
in	NULL
the	NULL
United	NULL
States	NULL
and	NULL
Europe	NULL
harbor	NULL
HTLV-II	NULL
(	NULL
25	NULL
,	NULL
36	NULL
,	NULL
49	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
virus	NULL
is	NULL
more	NULL
prevalent	NULL
in	NULL
the	NULL
population	NULL
than	NULL
first	NULL
estimated	NULL
.	NULL

HTLV	NULL
transforms	NULL
peripheral	NULL
blood	NULL
T	NULL
lymphocytes	NULL
in	NULL
vitro	NULL
,	NULL
as	NULL
defined	NULL
by	NULL
their	NULL
continuous	NULL
proliferation	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
exogenous	NULL
interleukin-2	NULL
(	NULL
7	NULL
,	NULL
34	NULL
,	NULL
50	NULL
)	NULL
,	NULL
even	NULL
though	NULL
its	NULL
genome	NULL
lacks	NULL
a	NULL
classical	NULL
oncogene	NULL
and	NULL
does	NULL
not	NULL
insert	NULL
at	NULL
specific	NULL
sites	NULL
within	NULL
the	NULL
host	NULL
genome	NULL
(	NULL
41	NULL
,	NULL
42	NULL
)	NULL
.	NULL

Three	NULL
mRNA	NULL
species	NULL
have	NULL
been	NULL
identified	NULL
for	NULL
HTLV	NULL
.	NULL

A	NULL
full-length	NULL
genomic	NULL
mRNA	NULL
(	NULL
8.2	NULL
kilobases	NULL
[	NULL
kb	NULL
]	NULL
)	NULL
and	NULL
a	NULL
subgenomic	NULL
mRNA	NULL
(	NULL
4.3	NULL
kb	NULL
)	NULL
,	NULL
in	NULL
which	NULL
one	NULL
intron	NULL
is	NULL
spliced	NULL
out	NULL
,	NULL
encode	NULL
the	NULL
characteristic	NULL
retroviral	NULL
Gag	NULL
and	NULL
Pol	NULL
proteins	NULL
and	NULL
Env	NULL
protein	NULL
,	NULL
respectively	NULL
.	NULL

A	NULL
second	NULL
subgenomic	NULL
mRNA	NULL
(	NULL
2.1	NULL
kb	NULL
)	NULL
,	NULL
which	NULL
has	NULL
an	NULL
additional	NULL
intron	NULL
removed	NULL
,	NULL
encodes	NULL
both	NULL
the	NULL
tax	NULL
and	NULL
rex	NULL
gene	NULL
products	NULL
via	NULL
translation	NULL
in	NULL
separate	NULL
overlapping	NULL
reading	NULL
frames	NULL
.	NULL

The	NULL
tax	NULL
reading	NULL
frame	NULL
produces	NULL
a	NULL
40-kilodalton	NULL
protein	NULL
in	NULL
HTLV-I	NULL
(	NULL
p40'*	NULL
)	NULL
and	NULL
a	NULL
37-kilodalton	NULL
protein	NULL
in	NULL
HTLV-II	NULL
(	NULL
p37	NULL
'	NULL
``	NULL
*	NULL
)	NULL
,	NULL
which	NULL
localizes	NULL
to	NULL
the	NULL
nucleus	NULL
of	NULL
infected	NULL
cells	NULL
(	NULL
12	NULL
,	NULL
21	NULL
,	NULL
29	NULL
,	NULL
46	NULL
)	NULL
.	NULL

Tax	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
increase	NULL
the	NULL
rate	NULL
of	NULL
transcription	NULL
from	NULL
the	NULL
viral	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
(	NULL
4	NULL
,	NULL
5	NULL
,	NULL
10	NULL
,	NULL
43	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
from	NULL
the	NULL
cellular	NULL
genes	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

4914	NULL
for	NULL
interleukin-2	NULL
(	NULL
26	NULL
)	NULL
,	NULL
the	NULL
interleukin-2	NULL
receptor	NULL
(	NULL
1	NULL
,	NULL
8	NULL
,	NULL
19	NULL
)	NULL
,	NULL
and	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
31	NULL
,	NULL
51	NULL
)	NULL
.	NULL

Several	NULL
studies	NULL
have	NULL
implicated	NULL
Tax	NULL
in	NULL
the	NULL
HTLV	NULL
oncogenic	NULL
process	NULL
(	NULL
14	NULL
,	NULL
30	NULL
,	NULL
48	NULL
)	NULL
.	NULL

The	NULL
rex	NULL
reading	NULL
frame	NULL
produces	NULL
two	NULL
proteins	NULL
of	NULL
27	NULL
and	NULL
21	NULL
kilodaltons	NULL
in	NULL
HTLV-I	NULL
(	NULL
p27'**	NULL
and	NULL
p21	NULL
``	NULL
**	NULL
)	NULL
(	NULL
23	NULL
)	NULL
and	NULL
26	NULL
and	NULL
24	NULL
kilodaltons	NULL
in	NULL
HTLV-II	NULL
(	NULL
p26	NULL
'	NULL
``	NULL
**	NULL
and	NULL
p24'*	NULL
)	NULL
(	NULL
37	NULL
,	NULL
44	NULL
)	NULL
.	NULL

Amino-terminal	NULL
deletions	NULL
of	NULL
Rex	NULL
coding	NULL
sequences	NULL
and	NULL
specific	NULL
point	NULL
mutations	NULL
which	NULL
abolish	NULL
Rex	NULL
protein	NULL
production	NULL
indicate	NULL
that	NULL
Rex	NULL
acts	NULL
posttranscriptionally	NULL
to	NULL
increase	NULL
the	NULL
ratio	NULL
of	NULL
incompletely	NULL
spliced	NULL
mRNAs	NULL
(	NULL
encoding	NULL
Gag	NULL
,	NULL
Pol	NULL
,	NULL
and	NULL
Env	NULL
proteins	NULL
)	NULL
to	NULL
completely	NULL
spliced	NULL
mRNA	NULL
(	NULL
encoding	NULL
Tax	NULL
and	NULL
Rex	NULL
)	NULL
,	NULL
resulting	NULL
in	NULL
highly	NULL
regulated	NULL
viral	NULL
gene	NULL
expression	NULL
(	NULL
16	NULL
,	NULL
17	NULL
,	NULL
20	NULL
)	NULL
.	NULL

The	NULL
individual	NULL
contribution	NULL
of	NULL
the	NULL
smaller	NULL
rex	NULL
gene	NULL
product	NULL
,	NULL
if	NULL
any	NULL
,	NULL
has	NULL
not	NULL
been	NULL
determined	NULL
.	NULL

The	NULL
precise	NULL
relationship	NULL
of	NULL
the	NULL
two	NULL
rex	NULL
gene	NULL
products	NULL
is	NULL
not	NULL
known	NULL
,	NULL
although	NULL
it	NULL
has	NULL
been	NULL
established	NULL
that	NULL
both	NULL
proteins	NULL
share	NULL
the	NULL
same	NULL
carboxy	NULL
terminus	NULL
(	NULL
28	NULL
)	NULL
.	NULL

One	NULL
study	NULL
which	NULL
involved	NULL
in	NULL
vitro	NULL
translation	NULL
of	NULL
in	NULL
vitro-synthesized	NULL
HTLV-I	NULL
RNA	NULL
containing	NULL
specific	NULL
site-directed	NULL
mutations	NULL
in	NULL
the	NULL
rex	NULL
open	NULL
reading	NULL
frame	NULL
demonstrated	NULL
that	NULL
deletion	NULL
of	NULL
an	NULL
internal	NULL
methionine	NULL
initiation	NULL
codon	NULL
resulted	NULL
in	NULL
the	NULL
loss	NULL
of	NULL
(	NULL
29	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggested	NULL
that	NULL
p21	NULL
'	NULL
``	NULL
*	NULL
is	NULL
synthesized	NULL
from	NULL
an	NULL
internal	NULL
methionine	NULL
initiation	NULL
codon	NULL
of	NULL
the	NULL
doubly	NULL
spliced	NULL
fax/rex	NULL
mRNA	NULL
.	NULL

Studies	NULL
corroborating	NULL
these	NULL
results	NULL
have	NULL
not	NULL
been	NULL
performed	NULL
in	NULL
infected	NULL
cells	NULL
,	NULL
due	NULL
to	NULL
the	NULL
lack	NULL
of	NULL
an	NULL
infectious	NULL
clone	NULL
of	NULL
HTLV-I	NULL
;	NULL
thus	NULL
,	NULL
the	NULL
function	NULL
of	NULL
the	NULL
smaller	NULL
Rex	NULL
protein	NULL
has	NULL
not	NULL
been	NULL
elucidated	NULL
.	NULL

By	NULL
using	NULL
an	NULL
infectious	NULL
clone	NULL
of	NULL
HTLV-II	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
importance	NULL
of	NULL
the	NULL
internal	NULL
methionine	NULL
codons	NULL
of	NULL
the	NULL
rex	NULL
gene	NULL
on	NULL
p24	NULL
``	NULL
production	NULL
,	NULL
viral	NULL
replication	NULL
,	NULL
and	NULL
transformation	NULL
.	NULL

By	NULL
using	NULL
site-directed	NULL
mutagenesis	NULL
,	NULL
the	NULL
internal	NULL
ATGs	NULL
in	NULL
the	NULL
rex	NULL
reading	NULL
frame	NULL
were	NULL
systematically	NULL
mutated	NULL
.	NULL

We	NULL
report	NULL
here	NULL
that	NULL
p24	NULL
``	NULL
*	NULL
is	NULL
not	NULL
initiated	NULL
at	NULL
an	NULL
internal	NULL
methionine	NULL
codon	NULL
and	NULL
that	NULL
the	NULL
internal	NULL
methionine	NULL
codons	NULL
are	NULL
not	NULL
crucial	NULL
to	NULL
the	NULL
function	NULL
of	NULL
the	NULL
rex	NULL
gene	NULL
.	NULL

Vor	NULL
.	NULL

64	NULL
,	NULL
1990	NULL
MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
lines	NULL
.	NULL

729-6	NULL
,	NULL
an	NULL
Epstein-Barr	NULL
virus-transformed	NULL
human	NULL
B-cell	NULL
line	NULL
,	NULL
was	NULL
maintained	NULL
in	NULL
Iscove	NULL
medium	NULL
supplemented	NULL
with	NULL
5	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
)	NULL
and	NULL
antibiotics	NULL
.	NULL

BJAB	NULL
,	NULL
an	NULL
Epstein-Barr-negative	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cell	NULL
line	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
W.	NULL
Hall	NULL
,	NULL
Cornell	NULL
University	NULL
)	NULL
,	NULL
was	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
and	NULL
antibiotics	NULL
.	NULL

Peripheral	NULL
blood	NULL
lymphocytes	NULL
were	NULL
isolated	NULL
by	NULL
centrifugation	NULL
over	NULL
Ficoll-Hypaque	NULL
of	NULL
fresh	NULL
blood	NULL
obtained	NULL
from	NULL
normal	NULL
donors	NULL
or	NULL
from	NULL
leukopacks	NULL
purchased	NULL
from	NULL
the	NULL
Red	NULL
Cross	NULL
.	NULL

These	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
20	NULL
%	NULL
FCS	NULL
and	NULL
antibiotics	NULL
.	NULL

Plasmids	NULL
and	NULL
mutagenesis	NULL
.	NULL

pHG6neo	NULL
,	NULL
an	NULL
HTLV-II	NULL
infectious	NULL
proviral	NULL
clone	NULL
,	NULL
LTR-II-CAT	NULL
,	NULL
and	NULL
SV2neo	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
6	NULL
,	NULL
45	NULL
)	NULL
.	NULL

Plasmids	NULL
with	NULL
the	NULL
prefix	NULL
``	NULL
BC	NULL
``	NULL
are	NULL
all	NULL
derived	NULL
from	NULL
the	NULL
plasmid	NULL
BC12/CMV/IL-2	NULL
(	NULL
9	NULL
)	NULL
,	NULL
which	NULL
contains	NULL
a	NULL
simian	NULL
virus	NULL
40	NULL
(	NULL
SV40	NULL
)	NULL
origin	NULL
of	NULL
replication	NULL
and	NULL
the	NULL
cytomegalovirus	NULL
immediate	NULL
early	NULL
promoter	NULL
.	NULL

Proper	NULL
insertion	NULL
of	NULL
genes	NULL
downstream	NULL
of	NULL
the	NULL
cytomegalovirus	NULL
promoter	NULL
results	NULL
in	NULL
high	NULL
levels	NULL
of	NULL
expression	NULL
in	NULL
729	NULL
cells	NULL
and	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
.	NULL

BCHTLV	NULL
contains	NULL
the	NULL
complete	NULL
coding	NULL
region	NULL
of	NULL
HTLV-II	NULL
(	NULL
BamHI-BamHI	NULL
,	NULL
nucleotides	NULL
[	NULL
nt	NULL
]	NULL
361	NULL
to	NULL
8550	NULL
)	NULL
and	NULL
expresses	NULL
all	NULL
viral	NULL
gene	NULL
products	NULL
.	NULL

BCHTLVCla	NULL
(	NULL
Tax~	NULL
and	NULL
Rex~T	NULL
)	NULL
,	NULL
BCHTLVSph	NULL
(	NULL
Rex~	NULL
)	NULL
,	NULL
and	NULL
BCHTLVrex	NULL
term	NULL
(	NULL
Rex~T	NULL
)	NULL
contain	NULL
rex	NULL
and/or	NULL
tax	NULL
mutations	NULL
that	NULL
have	NULL
been	NULL
previously	NULL
described	NULL
(	NULL
37	NULL
)	NULL
.	NULL

BCHTLV-UT	NULL
contains	NULL
a	NULL
deletion	NULL
in	NULL
the	NULL
apparently	NULL
nontranslated	NULL
region	NULL
between	NULL
nt	NULL
6660	NULL
and	NULL
6984	NULL
(	NULL
pH6neo-UT	NULL
contains	NULL
the	NULL
identical	NULL
deletion	NULL
in	NULL
the	NULL
pHG6neo	NULL
vector	NULL
)	NULL
.	NULL

BCHTLV-SA	NULL
contains	NULL
a	NULL
550-base-pair	NULL
(	NULL
bp	NULL
)	NULL
deletion	NULL
in	NULL
the	NULL
nontranslated	NULL
region	NULL
between	NULL
nt	NULL
6660	NULL
and	NULL
7210	NULL
,	NULL
which	NULL
also	NULL
results	NULL
in	NULL
removal	NULL
of	NULL
the	NULL
splice	NULL
acceptor	NULL
signal	NULL
sequence	NULL
for	NULL
tax/rex	NULL
exon	NULL
3	NULL
,	NULL
and	NULL
thus	NULL
is	NULL
Tax~	NULL
and	NULL
Rex~	NULL
(	NULL
pH6neo-SA	NULL
contains	NULL
the	NULL
identical	NULL
deletion	NULL
in	NULL
the	NULL
pH6neo	NULL
vector	NULL
)	NULL
.	NULL

Oligomer-directed	NULL
site-specific	NULL
mutagenesis	NULL
was	NULL
performed	NULL
in	NULL
the	NULL
M13-based	NULL
vector	NULL
,	NULL
Blue-script	NULL
KS+	NULL
(	NULL
Stratagene	NULL
)	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
Xhol-Sacl	NULL
fragment	NULL
of	NULL
pHG6neo	NULL
(	NULL
nt	NULL
6209	NULL
to	NULL
8662	NULL
)	NULL
,	NULL
by	NULL
the	NULL
method	NULL
described	NULL
by	NULL
Kunkel	NULL
(	NULL
24	NULL
)	NULL
.	NULL

The	NULL
three	NULL
internal	NULL
ATGs	NULL
in	NULL
the	NULL
rex	NULL
reading	NULL
frame	NULL
were	NULL
systematically	NULL
mutated	NULL
to	NULL
ACG	NULL
,	NULL
which	NULL
,	NULL
upon	NULL
translation	NULL
,	NULL
would	NULL
result	NULL
in	NULL
a	NULL
amino	NULL
acid	NULL
substitution	NULL
of	NULL
threonine	NULL
for	NULL
methionine	NULL
.	NULL

Mutations	NULL
were	NULL
confirmed	NULL
by	NULL
either	NULL
dideoxy	NULL
sequencing	NULL
or	NULL
Maxam-Gilbert	NULL
sequencing	NULL
(	NULL
27	NULL
,	NULL
39	NULL
)	NULL
.	NULL

These	NULL
mutations	NULL
were	NULL
designated	NULL
M1	NULL
(	NULL
nt	NULL
7248	NULL
,	NULL
T	NULL
to	NULL
C	NULL
)	NULL
,	NULL
M2	NULL
(	NULL
nt	NULL
7338	NULL
,	NULL
T	NULL
to	NULL
C	NULL
)	NULL
,	NULL
and	NULL
M3	NULL
(	NULL
nt	NULL
7389	NULL
,	NULL
T	NULL
to	NULL
C	NULL
)	NULL
and	NULL
were	NULL
cloned	NULL
back	NULL
into	NULL
the	NULL
vectors	NULL
described	NULL
above	NULL
(	NULL
pHGneo	NULL
and	NULL
BCHTLV	NULL
)	NULL
for	NULL
characterization	NULL
.	NULL

Electroporation	NULL
and	NULL
CAT	NULL
assays	NULL
.	NULL

Electroporations	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
by	NULL
using	NULL
a	NULL
Bio-Rad	NULL
gene	NULL
pulser	NULL
and	NULL
extender	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
,	NULL
counted	NULL
,	NULL
and	NULL
suspended	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
20	NULL
%	NULL
FCS	NULL
and	NULL
antibiotics	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
2	NULL
x	NULL
10	NULL
``	NULL
cells	NULL
per	NULL
ml	NULL
.	NULL

A	NULL
total	NULL
of	NULL
5	NULL
x	NULL
10°	NULL
cells	NULL
,	NULL
together	NULL
with	NULL
plasmid	NULL
DNA	NULL
,	NULL
were	NULL
exposed	NULL
to	NULL
a	NULL
960-uF	NULL
charge	NULL
with	NULL
a	NULL
250-V	NULL
potential	NULL
.	NULL

Cells	NULL
were	NULL
transferred	NULL
to	NULL
10	NULL
ml	NULL
of	NULL
medium	NULL
and	NULL
grown	NULL
at	NULL
37°C	NULL
for	NULL
48	NULL
h.	NULL
To	NULL
isolate	NULL
stable	NULL
transfectants	NULL
containing	NULL
pHGneo-derived	NULL
DNA	NULL
,	NULL
cells	NULL
were	NULL
plated	NULL
into	NULL
24-well	NULL
culture	NULL
dishes	NULL
(	NULL
5	NULL
x	NULL
10°	NULL
cells	NULL
per	NULL
well	NULL
)	NULL
under	NULL
G418	NULL
selection	NULL
(	NULL
1.5	NULL
mg/ml	NULL
;	NULL
GIBCO	NULL
Laboratories	NULL
)	NULL
.	NULL

Following	NULL
a	NULL
2-	NULL
to	NULL
3-week	NULL
selection	NULL
period	NULL
,	NULL
wells	NULL
which	NULL
grew	NULL
were	NULL
pooled	NULL
,	NULL
and	NULL
these	NULL
mass	NULL
cultures	NULL
were	NULL
maintained	NULL
for	NULL
further	NULL
analysis	NULL
.	NULL

Cell	NULL
extracts	NULL
for	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
assays	NULL
were	NULL
processed	NULL
48	NULL
h	NULL
posttransfection	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
13	NULL
)	NULL
.	NULL

CAT	NULL
reactions	NULL
were	NULL
standardized	NULL
for	NULL
equivalent	NULL
levels	NULL
of	NULL
protein	NULL
HTLV-II	NULL
rex	NULL
GENE	NULL
4915	NULL
(	NULL
determined	NULL
by	NULL
the	NULL
Bio-Rad	NULL
protein	NULL
assay	NULL
)	NULL
,	NULL
and	NULL
percentages	NULL
of	NULL
[	NULL
'*CJchloramphenicol	NULL
acetylation	NULL
were	NULL
quantified	NULL
by	NULL
scintillation	NULL
counting	NULL
of	NULL
excised	NULL
spots	NULL
.	NULL

Metabolic	NULL
labeling	NULL
and	NULL
immunoprecipitation	NULL
.	NULL

Stable	NULL
729	NULL
transfected	NULL
cell	NULL
lines	NULL
were	NULL
labeled	NULL
at	NULL
10°	NULL
cells	NULL
per	NULL
ml	NULL
with	NULL
[	NULL
?	NULL

*S	NULL
)	NULL
methionine-cysteine	NULL
ICN	NULL
Biochemicals	NULL
,	NULL
Inc.	NULL
[	NULL
100	NULL
pwCi/ml	NULL
]	NULL
)	NULL
in	NULL
methionine-cysteine-free	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
dialyzed	NULL
FCS	NULL
.	NULL

Cells	NULL
were	NULL
labeled	NULL
overnight	NULL
at	NULL
37°C	NULL
.	NULL

Cells	NULL
were	NULL
lysed	NULL
in	NULL
radioimmuno-precipitation	NULL
buffer	NULL
,	NULL
and	NULL
the	NULL
lysates	NULL
were	NULL
ultracentrifuged	NULL
at	NULL
100,000	NULL
x	NULL
g	NULL
for	NULL
1	NULL
h.	NULL
The	NULL
lysates	NULL
were	NULL
immunoprecipitated	NULL
by	NULL
using	NULL
either	NULL
HTLV-II-specific	NULL
human	NULL
antisera	NULL
or	NULL
antibody	NULL
directed	NULL
against	NULL
the	NULL
COOH-terminal	NULL
tridecapeptide	NULL
sequence	NULL
encoded	NULL
by	NULL
rex	NULL
(	NULL
44	NULL
)	NULL
.	NULL

Immune	NULL
complexes	NULL
were	NULL
collected	NULL
with	NULL
protein	NULL
A-Sepharose	NULL
(	NULL
Pharmacia	NULL
,	NULL
Inc.	NULL
)	NULL
,	NULL
and	NULL
the	NULL
proteins	NULL
were	NULL
separated	NULL
on	NULL
sodium	NULL
dodecyl	NULL
sulfate-polyacrylamide	NULL
gels	NULL
.	NULL

Gels	NULL
were	NULL
treated	NULL
with	NULL
(	NULL
Dupont	NULL
,	NULL
NEN	NULL
Research	NULL
Products	NULL
)	NULL
for	NULL
fluorography	NULL
and	NULL
exposed	NULL
to	NULL
X-Omat	NULL
R	NULL
film	NULL
(	NULL
Eastman	NULL
Kodak	NULL
Co.	NULL
)	NULL
.	NULL

DNA	NULL
transfer	NULL
and	NULL
hybridization	NULL
.	NULL

High-molecular-weight	NULL
DNA	NULL
was	NULL
extracted	NULL
from	NULL
stable	NULL
729	NULL
transfectants	NULL
or	NULL
HTLV-II-infected	NULL
BJAB	NULL
cells	NULL
and	NULL
analyzed	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Southern	NULL
(	NULL
47	NULL
)	NULL
,	NULL
as	NULL
described	NULL
elsewhere	NULL
(	NULL
15	NULL
)	NULL
.	NULL

The	NULL
probe	NULL
consisted	NULL
of	NULL
an	NULL
HTLV	NULL
(	NULL
1,176	NULL
bp	NULL
Xhol-Clal	NULL
fragment	NULL
)	NULL
*P-oligo-labeled	NULL
fragment	NULL
.	NULL

RNA	NULL
preparation	NULL
and	NULL
S1	NULL
nuclease	NULL
analysis	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
was	NULL
prepared	NULL
by	NULL
lysing	NULL
the	NULL
cells	NULL
in	NULL
4.7	NULL
M	NULL
urea-1.3	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate-0.23	NULL
M	NULL
NaCl-6.7	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
8.0	NULL
)	NULL
-0.67	NULL
mM	NULL
EDTA	NULL
,	NULL
followed	NULL
by	NULL
three	NULL
phenol-chloroform	NULL
extractions	NULL
.	NULL

RNA	NULL
was	NULL
pelleted	NULL
by	NULL
ultracentrifugation	NULL
through	NULL
a	NULL
CsCl	NULL
pad	NULL
(	NULL
30,000	NULL
rpm	NULL
for	NULL
16	NULL
h	NULL
)	NULL
,	NULL
suspended	NULL
in	NULL
10	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
7.6-1	NULL
mM	NULL
EDTA	NULL
,	NULL
and	NULL
the	NULL
concentration	NULL
was	NULL
determined	NULL
by	NULL
spectrophotometry	NULL
.	NULL

S1	NULL
nuclease	NULL
analysis	NULL
was	NULL
performed	NULL
with	NULL
25	NULL
ug	NULL
of	NULL
total	NULL
RNA	NULL
(	NULL
5	NULL
ug	NULL
of	NULL
sample	NULL
RNA	NULL
and	NULL
20	NULL
pg	NULL
of	NULL
uninfected	NULL
cell	NULL
RNA	NULL
)	NULL
and	NULL
a	NULL
[	NULL
y-	NULL
>	NULL
P	NULL
]	NULL
dATP-labeled	NULL
90-nt	NULL
oligonucleotide	NULL
probe	NULL
for	NULL
the	NULL
cap	NULL
site	NULL
of	NULL
HTLV-II	NULL
(	NULL
nt	NULL
294	NULL
to	NULL
383	NULL
)	NULL
,	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
2	NULL
)	NULL
.	NULL

RESULTS	NULL
Construction	NULL
of	NULL
rex	NULL
internal	NULL
methionine	NULL
codon	NULL
mutants	NULL
.	NULL

Figure	NULL
1	NULL
shows	NULL
the	NULL
genomic	NULL
structure	NULL
of	NULL
HTLV-II	NULL
and	NULL
the	NULL
single	NULL
2.1-kb	NULL
doubly	NULL
spliced	NULL
mRNA	NULL
which	NULL
encodes	NULL
the	NULL
trans-regulatory	NULL
gene	NULL
products	NULL
,	NULL
Tax	NULL
and	NULL
Rex	NULL
,	NULL
in	NULL
separate	NULL
but	NULL
partially	NULL
overlapping	NULL
reading	NULL
frames	NULL
.	NULL

The	NULL
well-characterized	NULL
methionine	NULL
(	NULL
Met	NULL
)	NULL
initiation	NULL
codon	NULL
for	NULL
the	NULL
larger	NULL
Rex	NULL
species	NULL
(	NULL
p26	NULL
)	NULL
is	NULL
at	NULL
nt	NULL
5121	NULL
.	NULL

The	NULL
Met	NULL
initiator	NULL
codon	NULL
for	NULL
the	NULL
trans-activator	NULL
protein	NULL
,	NULL
p37	NULL
``	NULL
,	NULL
is	NULL
located	NULL
downstream	NULL
at	NULL
nt	NULL
5180	NULL
.	NULL

Previous	NULL
HTLV-I	NULL
rex	NULL
gene	NULL
mutagenesis	NULL
studies	NULL
have	NULL
suggested	NULL
that	NULL
the	NULL
smaller	NULL
rex	NULL
gene	NULL
product	NULL
,	NULL
p21	NULL
'	NULL
``	NULL
,	NULL
is	NULL
initiated	NULL
at	NULL
an	NULL
internal	NULL
Met	NULL
codon	NULL
.	NULL

The	NULL
HTLV-II	NULL
rex	NULL
gene	NULL
contains	NULL
three	NULL
potential	NULL
internal	NULL
Met	NULL
initiation	NULL
codons	NULL
located	NULL
at	NULL
nt	NULL
7248	NULL
,	NULL
7338	NULL
,	NULL
and	NULL
7389	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
,	NULL
the	NULL
latter	NULL
of	NULL
which	NULL
corresponds	NULL
to	NULL
the	NULL
one	NULL
in	NULL
HTLV-I	NULL
that	NULL
was	NULL
thought	NULL
to	NULL
be	NULL
responsible	NULL
for	NULL
p21	NULL
``	NULL
**	NULL
production	NULL
(	NULL
29	NULL
)	NULL
.	NULL

The	NULL
internal	NULL
Met	NULL
codons	NULL
of	NULL
the	NULL
HTLV-II	NULL
rex	NULL
gene	NULL
were	NULL
systematically	NULL
mutated	NULL
to	NULL
code	NULL
for	NULL
threonine	NULL
(	NULL
Thr	NULL
)	NULL
by	NULL
site-directed	NULL
mutagenesis	NULL
.	NULL

Both	NULL
Tax	NULL
and	NULL
Rex	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
critical	NULL
for	NULL
viral	NULL
replication	NULL
and	NULL
transformation	NULL
.	NULL

Since	NULL
Tax	NULL
and	NULL
Rex	NULL
are	NULL
encoded	NULL
in	NULL
partially	NULL
overlapping	NULL
reading	NULL
frames	NULL
,	NULL
informative	NULL
mutagenesis	NULL
studies	NULL
require	NULL
that	NULL
the	NULL
rex	NULL
mutations	NULL
be	NULL
silent	NULL
in	NULL
the	NULL
tax	NULL
reading	NULL
frame	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
HTLV-II	NULL
rex	NULL
gene	NULL
mutants	NULL
,	NULL
referred	NULL
to	NULL
as	NULL
M1	NULL
,	NULL
M2	NULL
,	NULL
and	NULL
M3	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
,	NULL
were	NULL
designed	NULL
so	NULL
as	NULL
not	NULL
to	NULL
alter	NULL
the	NULL
amino	NULL
acid	NULL
sequence	NULL
of	NULL
Tax	NULL
;	NULL
the	NULL
mutations	NULL
were	NULL
confirmed	NULL
by	NULL
sequencing	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

4916	NULL
GREEN	NULL
ET	NULL
AL	NULL
.	NULL

<	NULL
@	NULL
-	NULL
t	NULL
J.	NULL
Viror	NULL
.	NULL

e	NULL
B	NULL
5LTR	NULL
D	NULL
gag	NULL
pol	NULL
3LTR	NULL
env	NULL
UT	NULL
tax/rex	NULL
m	NULL
>	NULL
>	NULL
#	NULL
)	NULL
Rex	NULL
p26	NULL
and	NULL
p24	NULL
9	NULL
5044	NULL
5183	NULL
7214	NULL
8751	NULL
oo	NULL
_	NULL
_ﬁ~_	NULL
_	NULL
Aj	NULL
Ct	NULL
-L	NULL
-	NULL
``	NULL
-	NULL
cet	NULL
AUI	NULL
-	NULL
-	NULL
fred	NULL
fun	NULL
~~	NULL
_	NULL
dan	NULL
5121	NULL
5180	NULL
M1	NULL
AUG	NULL
AUG	NULL
(	NULL
7338	NULL
)	NULL
(	NULL
7389	NULL
)	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Structural	NULL
features	NULL
of	NULL
the	NULL
HTLV-II	NULL
genome	NULL
and	NULL
HTLV-II	NULL
tax/rex	NULL
mRNA	NULL
and	NULL
coding	NULL
sequence	NULL
.	NULL

The	NULL
complete	NULL
proviral	NULL
genome	NULL
is	NULL
shown	NULL
schematically	NULL
.	NULL

Boxes	NULL
depict	NULL
the	NULL
LTRs	NULL
,	NULL
and	NULL
vertical	NULL
lines	NULL
mark	NULL
the	NULL
beginnings	NULL
and	NULL
ends	NULL
of	NULL
the	NULL
gag	NULL
,	NULL
pol	NULL
,	NULL
env	NULL
,	NULL
and	NULL
trax/rex	NULL
genes	NULL
and	NULL
the	NULL
nontranslated	NULL
region	NULL
(	NULL
UT	NULL
)	NULL
.	NULL

Pertinent	NULL
restriction	NULL
enzyme	NULL
recognition	NULL
sites	NULL
are	NULL
listed	NULL
(	NULL
B	NULL
,	NULL
BamHI	NULL
;	NULL
C	NULL
,	NULL
Clal	NULL
;	NULL
M	NULL
,	NULL
Miul	NULL
)	NULL
.	NULL

The	NULL
2.1-kb	NULL
doubly	NULL
spliced	NULL
taxirex	NULL
mRNA	NULL
and	NULL
the	NULL
Tax	NULL
and	NULL
Rex	NULL
coding	NULL
sequences	NULL
and	NULL
protein	NULL
sizes	NULL
are	NULL
represented	NULL
below	NULL
the	NULL
genome	NULL
.	NULL

The	NULL
tax	NULL
AUG	NULL
(	NULL
nt	NULL
5180	NULL
)	NULL
and	NULL
rex	NULL
AUG	NULL
(	NULL
nt	NULL
5121	NULL
)	NULL
are	NULL
indicated	NULL
.	NULL

The	NULL
three	NULL
internal	NULL
methionine	NULL
(	NULL
AUG	NULL
)	NULL
codons	NULL
(	NULL
M1	NULL
,	NULL
M2	NULL
,	NULL
and	NULL
M3	NULL
)	NULL
,	NULL
which	NULL
were	NULL
mutated	NULL
to	NULL
code	NULL
for	NULL
threonine	NULL
in	NULL
this	NULL
study	NULL
,	NULL
and	NULL
their	NULL
nucleotide	NULL
locations	NULL
in	NULL
the	NULL
rex	NULL
reading	NULL
frame	NULL
,	NULL
based	NULL
on	NULL
the	NULL
HTLV-II	NULL
pH6neo	NULL
proviral	NULL
sequence	NULL
,	NULL
are	NULL
indicated	NULL
.	NULL

Functional	NULL
analysis	NULL
of	NULL
rex	NULL
mutants	NULL
by	NULL
CAT	NULL
assay	NULL
.	NULL

The	NULL
rex	NULL
gene	NULL
Met	NULL
codon	NULL
mutants	NULL
described	NULL
above	NULL
were	NULL
inserted	NULL
into	NULL
full-length	NULL
viral	NULL
expression	NULL
plasmids	NULL
,	NULL
and	NULL
their	NULL
ability	NULL
to	NULL
trans	NULL
activate	NULL
LTR-linked	NULL
gene	NULL
expression	NULL
was	NULL
determined	NULL
in	NULL
CAT	NULL
assays	NULL
.	NULL

The	NULL
pH6neo	NULL
vector	NULL
contains	NULL
the	NULL
complete	NULL
HTLV-II	NULL
provirus	NULL
,	NULL
and	NULL
transcription	NULL
from	NULL
the	NULL
native	NULL
LTR	NULL
responds	NULL
to	NULL
regulation	NULL
by	NULL
the	NULL
frans-regulatory	NULL
gene	NULL
products	NULL
,	NULL
Tax	NULL
and	NULL
Rex	NULL
.	NULL

BCHTLV	NULL
contains	NULL
the	NULL
complete	NULL
coding	NULL
regions	NULL
of	NULL
HTLV-II	NULL
under	NULL
the	NULL
transcriptional	NULL
control	NULL
of	NULL
the	NULL
cytomegalovirus	NULL
immediate	NULL
early	NULL
promoter	NULL
,	NULL
resulting	NULL
in	NULL
con-stitutive	NULL
viral	NULL
gene	NULL
expression	NULL
.	NULL

This	NULL
vector	NULL
is	NULL
analogous	NULL
to	NULL
SV-HTLV	NULL
,	NULL
previously	NULL
reported	NULL
using	NULL
the	NULL
SV40	NULL
early	NULL
promoter	NULL
(	NULL
37	NULL
)	NULL
.	NULL

We	NULL
previously	NULL
reported	NULL
that	NULL
loss	NULL
of	NULL
Rex	NULL
function	NULL
results	NULL
in	NULL
a	NULL
decrease	NULL
in	NULL
LTR-directed	NULL
gene	NULL
expression	NULL
as	NULL
measured	NULL
by	NULL
CAT	NULL
activity	NULL
,	NULL
which	NULL
can	NULL
be	NULL
complemented	NULL
by	NULL
addition	NULL
of	NULL
Rex	NULL
in	NULL
trans	NULL
(	NULL
37	NULL
)	NULL
.	NULL

This	NULL
altered	NULL
LTR	NULL
activity	NULL
is	NULL
due	NULL
to	NULL
a	NULL
combination	NULL
of	NULL
both	NULL
a	NULL
Tax	NULL
effect	NULL
at	NULL
the	NULL
level	NULL
of	NULL
transcription	NULL
and	NULL
a	NULL
Rex	NULL
effect	NULL
that	NULL
is	NULL
posttranscriptional	NULL
.	NULL

We	NULL
used	NULL
this	NULL
assay	NULL
to	NULL
determine	NULL
whether	NULL
our	NULL
internal	NULL
rex	NULL
Met	NULL
codon	NULL
mutants	NULL
were	NULL
functional	NULL
.	NULL

TABLE	NULL
1	NULL
.	NULL

Base	NULL
substitutions	NULL
in	NULL
tax/rex	NULL
coding	NULL
region	NULL
Protein	NULL
amino	NULL
acid	NULL
change	NULL
Mutation	NULL
name/	NULL
Nucleotide	NULL
nucleotide	NULL
``	NULL
base	NULL
change	NULL
Rex	NULL
Tax	NULL
Cla/7386	NULL
+CG	NULL
fs®/Ser-79	NULL
fs	NULL
``	NULL
/Ile-59	NULL
Sph/5120-5123	NULL
-CATG	NULL
AMet-1	NULL
No	NULL
effect	NULL
rex	NULL
term/7386	NULL
C-A	NULL
Ser-79-	NULL
>	NULL
Stop	NULL
No	NULL
effect	NULL
M1/7248	NULL
T-C	NULL
Met-33-Thr	NULL
No	NULL
effect	NULL
M2/7338	NULL
T-C	NULL
Met-63-Thr	NULL
No	NULL
effect	NULL
M3/7389	NULL
T-C	NULL
Met-80-Thr	NULL
No	NULL
effect	NULL
°	NULL
Mutations	NULL
Cla	NULL
,	NULL
Sph	NULL
,	NULL
and	NULL
rex	NULL
term	NULL
have	NULL
been	NULL
previously	NULL
described	NULL
(	NULL
37	NULL
)	NULL
.	NULL

The	NULL
Cla	NULL
mutation	NULL
frameshifts	NULL
both	NULL
rex	NULL
(	NULL
79	NULL
amino	NULL
acids	NULL
in	NULL
frame	NULL
plus	NULL
192	NULL
amino	NULL
acids	NULL
out	NULL
of	NULL
frame	NULL
)	NULL
and	NULL
rax	NULL
(	NULL
59	NULL
amino	NULL
acids	NULL
in	NULL
frame	NULL
plus	NULL
92	NULL
amino	NULL
acids	NULL
out	NULL
of	NULL
frame	NULL
)	NULL
.	NULL

The	NULL
Sph	NULL
mutation	NULL
deletes	NULL
the	NULL
first	NULL
initiator	NULL
Met	NULL
codon	NULL
of	NULL
rex	NULL
,	NULL
resulting	NULL
in	NULL
loss	NULL
of	NULL
Rex	NULL
production	NULL
and	NULL
function	NULL
.	NULL

The	NULL
rex	NULL
term	NULL
truncates	NULL
Rex	NULL
at	NULL
amino	NULL
acid	NULL
79	NULL
.	NULL

M1	NULL
,	NULL
M2	NULL
,	NULL
and	NULL
M3	NULL
were	NULL
made	NULL
by	NULL
site-directed	NULL
mutagenesis	NULL
,	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Nucleotide	NULL
and	NULL
amino	NULL
acid	NULL
numbers	NULL
are	NULL
based	NULL
on	NULL
the	NULL
nucleotide	NULL
sequerice	NULL
and	NULL
Tax	NULL
(	NULL
331	NULL
amino	NULL
acids	NULL
)	NULL
and	NULL
Rex	NULL
(	NULL
170	NULL
amino	NULL
acids	NULL
)	NULL
protein	NULL
sequences	NULL
of	NULL
the	NULL
HTLV-II	NULL
proviral	NULL
clone	NULL
,	NULL
pH6neo	NULL
.	NULL

®	NULL
fs	NULL
,	NULL
Frameshift	NULL
.	NULL

Wild-type	NULL
and	NULL
tax	NULL
and/or	NULL
rex	NULL
mutant	NULL
HTLV-II	NULL
expression	NULL
vectors	NULL
were	NULL
cotransfected	NULL
with	NULL
LTR-II-CAT	NULL
into	NULL
729	NULL
B	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
functional	NULL
levels	NULL
of	NULL
Tax	NULL
and	NULL
Rex	NULL
were	NULL
monitored	NULL
by	NULL
measuring	NULL
the	NULL
amount	NULL
of	NULL
CAT	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

The	NULL
wild-type	NULL
constructs	NULL
(	NULL
BCHTLV	NULL
and	NULL
pH6neo	NULL
)	NULL
significantly	NULL
activated	NULL
the	NULL
HTLV-II	NULL
LTR	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
percent	NULL
acetylation	NULL
indicated	NULL
that	NULL
the	NULL
cytomegalovirus	NULL
promoter	NULL
is	NULL
more	NULL
active	NULL
than	NULL
the	NULL
HTLV-II	NULL
promoter	NULL
in	NULL
729	NULL
cells	NULL
(	NULL
88-fold	NULL
versus	NULL
15-fold	NULL
over	NULL
background	NULL
)	NULL
.	NULL

A	NULL
mutation	NULL
which	NULL
frameshifts	NULL
both	NULL
rax	NULL
and	NULL
rex	NULL
(	NULL
BCHTLVCla	NULL
)	NULL
results	NULL
in	NULL
no	NULL
trans	NULL
activation	NULL
above	NULL
baseline	NULL
levels	NULL
,	NULL
as	NULL
previously	NULL
reported	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
first	NULL
rex	NULL
ATG	NULL
(	NULL
BCHTLVSph	NULL
)	NULL
or	NULL
a	NULL
mutation	NULL
resulting	NULL
in	NULL
premature	NULL
termination	NULL
of	NULL
rex	NULL
(	NULL
BCHTLVrex	NULL
term	NULL
)	NULL
,	NULL
both	NULL
of	NULL
which	NULL
do	NULL
not	NULL
alter	NULL
tax	NULL
,	NULL
significantly	NULL
reduced	NULL
CAT	NULL
activity	NULL
as	NULL
compared	NULL
with	NULL
the	NULL
wild	NULL
type	NULL
,	NULL
confirming	NULL
previous	NULL
results	NULL
that	NULL
HTLV-II	NULL
Rex	NULL
influences	NULL
LTR-directed	NULL
gene	NULL
expression	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Two	NULL
additional	NULL
mutants	NULL
tested	NULL
and	NULL
used	NULL
as	NULL
positive	NULL
and	NULL
negative	NULL
controls	NULL
throughout	NULL
these	NULL
studies	NULL
are	NULL
BCHTLV-UT/pH6neo-UT	NULL
and	NULL
BCHTLV-SA/pH6neo-SA	NULL
,	NULL
respectively	NULL
.	NULL

Both	NULL
mutants	NULL
contain	NULL
deletions	NULL
in	NULL
the	NULL
nontranslated	NULL
Acetylation	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Representative	NULL
CAT	NULL
assay	NULL
.	NULL

LTR-II-CAT	NULL
and	NULL
various	NULL
HTLV-II	NULL
expression	NULL
constructs	NULL
indicated	NULL
above	NULL
were	NULL
introduced	NULL
into	NULL
729	NULL
B	NULL
cells	NULL
,	NULL
and	NULL
percent	NULL
acetylation	NULL
was	NULL
measured	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Various	NULL
mutations	NULL
(	NULL
described	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
were	NULL
analyzed	NULL
in	NULL
the	NULL
context	NULL
of	NULL
complete	NULL
HTLV-II	NULL
genomes	NULL
expressed	NULL
either	NULL
from	NULL
their	NULL
own	NULL
promoter	NULL
(	NULL
pHGneo-derived	NULL
constructs	NULL
)	NULL
or	NULL
from	NULL
the	NULL
cytomegalovirus	NULL
early	NULL
promoter	NULL
(	NULL
BCHTLV-derived	NULL
constructs	NULL
)	NULL
.	NULL

Vor	NULL
.	NULL

64	NULL
,	NULL
1990	NULL
<	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Southern	NULL
hybridization	NULL
analysis	NULL
of	NULL
the	NULL
729	NULL
stable	NULL
transfectant	NULL
cell	NULL
DNA	NULL
.	NULL

Ten	NULL
micrograms	NULL
of	NULL
high-molecular-weight	NULL
cell	NULL
DNA	NULL
,	NULL
as	NULL
labeled	NULL
,	NULL
was	NULL
double	NULL
digested	NULL
with	NULL
BamHI	NULL
and	NULL
Clal	NULL
or	NULL
with	NULL
BamHI	NULL
and	NULL
Miul	NULL
(	NULL
indicated	NULL
by	NULL
an	NULL
asterisk	NULL
)	NULL
,	NULL
electrophoresed	NULL
through	NULL
a	NULL
0.7	NULL
%	NULL
agarose	NULL
gel	NULL
,	NULL
blotted	NULL
to	NULL
nitrocellulose	NULL
paper	NULL
,	NULL
and	NULL
hybridized	NULL
with	NULL
a	NULL
*°P-labeled	NULL
,	NULL
HTLV-II-specific	NULL
1,176-bp	NULL
probe	NULL
(	NULL
Xhol	NULL
[	NULL
nt	NULL
6209	NULL
]	NULL
-Cial	NULL
[	NULL
nt	NULL
7384	NULL
]	NULL
)	NULL
.	NULL

The	NULL
labeled	NULL
arrows	NULL
,	NULL
in	NULL
base	NULL
pairs	NULL
,	NULL
indicate	NULL
approximate	NULL
sizes	NULL
of	NULL
expected	NULL
HTLV-II-specific	NULL
fragments	NULL
and	NULL
were	NULL
determined	NULL
by	NULL
comparison	NULL
with	NULL
HindIII	NULL
digests	NULL
of	NULL
lambda	NULL
and	NULL
SV40	NULL
DNAs	NULL
.	NULL

region	NULL
between	NULL
env	NULL
and	NULL
tax/rex	NULL
exon	NULL
3	NULL
.	NULL

However	NULL
,	NULL
the	NULL
SA	NULL
deletion	NULL
removes	NULL
all	NULL
but	NULL
four	NULL
nucleotides	NULL
of	NULL
the	NULL
splice	NULL
acceptor	NULL
site	NULL
for	NULL
rax/rex	NULL
exon	NULL
3	NULL
,	NULL
which	NULL
should	NULL
abolish	NULL
normal	NULL
splicing	NULL
of	NULL
fax/rex	NULL
mRNA	NULL
and	NULL
interfere	NULL
with	NULL
production	NULL
of	NULL
Tax	NULL
and	NULL
Rex	NULL
.	NULL

When	NULL
tested	NULL
in	NULL
CAT	NULL
assays	NULL
,	NULL
the	NULL
UT	NULL
mutant	NULL
shows	NULL
wild-type	NULL
CAT	NULL
activity	NULL
,	NULL
and	NULL
as	NULL
expected	NULL
,	NULL
the	NULL
SA	NULL
mutant	NULL
is	NULL
incapable	NULL
of	NULL
trans	NULL
activation	NULL
.	NULL

The	NULL
CAT	NULL
activities	NULL
of	NULL
the	NULL
rex	NULL
Met	NULL
codon	NULL
mutants	NULL
,	NULL
M1	NULL
,	NULL
M2	NULL
,	NULL
and	NULL
M3	NULL
,	NULL
are	NULL
comparable	NULL
to	NULL
wild-type	NULL
levels	NULL
,	NULL
indicating	NULL
that	NULL
both	NULL
Tax	NULL
and	NULL
Rex	NULL
are	NULL
fully	NULL
functional	NULL
in	NULL
this	NULL
assay	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
similar	NULL
relative	NULL
activities	NULL
were	NULL
seen	NULL
with	NULL
the	NULL
rex	NULL
Met	NULL
codon	NULL
mutants	NULL
in	NULL
the	NULL
two	NULL
vector	NULL
systems	NULL
(	NULL
BCHTLYV	NULL
or	NULL
pH6neo	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
in	NULL
this	NULL
functional	NULL
analysis	NULL
of	NULL
Tax	NULL
and	NULL
Rex	NULL
,	NULL
vector	NULL
transcriptional	NULL
control	NULL
is	NULL
not	NULL
a	NULL
factor	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
mutation	NULL
of	NULL
the	NULL
internal	NULL
methionine	NULL
codons	NULL
for	NULL
the	NULL
rex	NULL
gene	NULL
does	NULL
not	NULL
impair	NULL
the	NULL
function	NULL
of	NULL
the	NULL
protein	NULL
as	NULL
measured	NULL
in	NULL
transient	NULL
CAT	NULL
assays	NULL
,	NULL
whereas	NULL
mutation	NULL
of	NULL
the	NULL
initial	NULL
Met	NULL
codon	NULL
or	NULL
rex	NULL
carboxy-terminal	NULL
truncation	NULL
abolishes	NULL
Rex	NULL
activity	NULL
.	NULL

Isolation	NULL
of	NULL
stable	NULL
transfectants	NULL
.	NULL

To	NULL
further	NULL
characterize	NULL
effects	NULL
of	NULL
mutations	NULL
within	NULL
the	NULL
rex	NULL
gene	NULL
on	NULL
aspects	NULL
of	NULL
the	NULL
virus	NULL
life	NULL
cycle	NULL
,	NULL
including	NULL
RNA	NULL
expression	NULL
,	NULL
protein	NULL
production	NULL
,	NULL
and	NULL
budding	NULL
of	NULL
infectious	NULL
virions	NULL
,	NULL
stable	NULL
729	NULL
cell	NULL
transfectants	NULL
containing	NULL
pHG6neoM1L	NULL
,	NULL
pHGneoM2	NULL
,	NULL
and	NULL
pH6neoM3	NULL
,	NULL
along	NULL
with	NULL
positive	NULL
and	NULL
negative	NULL
controls	NULL
,	NULL
were	NULL
isolated	NULL
.	NULL

Stable	NULL
transfectants	NULL
are	NULL
prefixed	NULL
by	NULL
©729	NULL
,	NULL
``	NULL
followed	NULL
by	NULL
the	NULL
full-length	NULL
HTLV-II	NULL
proviral	NULL
clone	NULL
with	NULL
which	NULL
they	NULL
were	NULL
transfected	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
729pHGneo	NULL
is	NULL
a	NULL
stable	NULL
line	NULL
transfected	NULL
with	NULL
the	NULL
clone	NULL
pH6neo	NULL
)	NULL
.	NULL

To	NULL
confirm	NULL
the	NULL
presence	NULL
of	NULL
HTLV-II	NULL
proviral	NULL
DNA	NULL
in	NULL
the	NULL
stable	NULL
transfectants	NULL
,	NULL
cell	NULL
DNA	NULL
was	NULL
analyzed	NULL
by	NULL
nucleic	NULL
acid	NULL
hybridization	NULL
following	NULL
digestion	NULL
with	NULL
diagnostic	NULL
restriction	NULL
endonucleases	NULL
(	NULL
BamHI	NULL
,	NULL
Clal	NULL
,	NULL
and	NULL
M/ul	NULL
)	NULL
.	NULL

All	NULL
stable	NULL
transfectants	NULL
analyzed	NULL
contained	NULL
complete	NULL
copies	NULL
of	NULL
the	NULL
HTLV-II	NULL
rex	NULL
GENE	NULL
491	NULL
%	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

S1	NULL
nuclease	NULL
analysis	NULL
of	NULL
729	NULL
stable	NULL
transfectant	NULL
RNA	NULL
Total	NULL
cellular	NULL
RNA	NULL
was	NULL
prepared	NULL
from	NULL
stable	NULL
transfectants	NULL
,	NULL
a	NULL
:	NULL
described	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

A	NULL
total	NULL
of	NULL
25	NULL
ug	NULL
of	NULL
RNA	NULL
(	NULL
(	NULL
ug	NULL
of	NULL
transfectant	NULL
RNA	NULL
,	NULL
as	NULL
labeled	NULL
in	NULL
the	NULL
figure	NULL
,	NULL
and	NULL
20	NULL
ug	NULL
oi	NULL
negative	NULL
control	NULL
729	NULL
RNA	NULL
)	NULL
was	NULL
subjected	NULL
to	NULL
S1	NULL
nuclease	NULL
analysi	NULL
:	NULL
with	NULL
a	NULL
[	NULL
y-*°P	NULL
]	NULL
JdATP-labeled	NULL
90-nt	NULL
oligonucleotide	NULL
which	NULL
spans	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
of	NULL
HTLV-II	NULL
.	NULL

A	NULL
70-nt	NULL
fragment	NULL
is	NULL
protected	NULL
by	NULL
mRNA	NULL
synthesized	NULL
from	NULL
the	NULL
cap	NULL
site	NULL
.	NULL

The	NULL
90-nt	NULL
fragment	NULL
protectec	NULL
is	NULL
due	NULL
to	NULL
complete	NULL
protection	NULL
of	NULL
the	NULL
probe	NULL
by	NULL
the	NULL
3	NULL
'	NULL
terminus	NULL
of	NULL
the	NULL
RNA	NULL
due	NULL
to	NULL
redundancy	NULL
of	NULL
sequences	NULL
in	NULL
the	NULL
LTR	NULL
.	NULL

The	NULL
labelec	NULL
arrows	NULL
,	NULL
in	NULL
base	NULL
pairs	NULL
,	NULL
are	NULL
marker	NULL
sizes	NULL
(	NULL
y-*P-end-labeled	NULL
pGEM	NULL
digested	NULL
with	NULL
Sau3A	NULL
)	NULL
.	NULL

HTLV-II	NULL
provirus	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Comparison	NULL
of	NULL
hybridization	NULL
intensities	NULL
of	NULL
the	NULL
predicted	NULL
size	NULL
fragments	NULL
in	NULL
the	NULL
different	NULL
transfectants	NULL
indicates	NULL
that	NULL
HTLV-II	NULL
DNA	NULL
is	NULL
present	NULL
in	NULL
similar	NULL
copy	NULL
number	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

The	NULL
729pH6neoM:2	NULL
cell	NULL
line	NULL
DNA	NULL
can	NULL
be	NULL
distinguished	NULL
from	NULL
both	NULL
the	NULL
wild-type	NULL
(	NULL
729pH6neo	NULL
)	NULL
and	NULL
other	NULL
mutant	NULL
(	NULL
729pH6neoMI1	NULL
and	NULL
729pHGneoM2	NULL
)	NULL
cell	NULL
line	NULL
DNAs	NULL
,	NULL
since	NULL
the	NULL
M3	NULL
mutation	NULL
resulted	NULL
in	NULL
loss	NULL
of	NULL
the	NULL
Clal	NULL
restriction	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

The	NULL
smaller	NULL
sizes	NULL
of	NULL
the	NULL
hybridizing	NULL
bands	NULL
in	NULL
both	NULL
729pH6neo-UT	NULL
and	NULL
729pH6neo-SA	NULL
also	NULL
confirms	NULL
the	NULL
respective	NULL
deletions	NULL
of	NULL
324	NULL
and	NULL
550	NULL
bp	NULL
in	NULL
the	NULL
nontranslated	NULL
region	NULL
.	NULL

Cell	NULL
lines	NULL
containing	NULL
pHG6neoM1Ll	NULL
and	NULL
pHG6neoM2	NULL
DNA	NULL
,	NULL
which	NULL
can	NULL
not	NULL
be	NULL
distinguished	NULL
from	NULL
wild-type	NULL
DNA	NULL
(	NULL
pH6neo	NULL
)	NULL
by	NULL
restriction	NULL
enzyme	NULL
mapping	NULL
,	NULL
were	NULL
confirmed	NULL
by	NULL
direct	NULL
sequencing	NULL
of	NULL
polymerase	NULL
chain	NULL
reaction-amplified	NULL
products	NULL
of	NULL
stable	NULL
transfectant	NULL
cell	NULL
DNA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
stable	NULL
729	NULL
cell	NULL
transfectants	NULL
have	NULL
integrated	NULL
full-length	NULL
HTLV-II	NULL
proviral	NULL
DNA	NULL
and	NULL
the	NULL
constructed	NULL
mutations	NULL
are	NULL
still	NULL
present	NULL
following	NULL
transfectior	NULL
and	NULL
selection	NULL
.	NULL

Expression	NULL
of	NULL
viral	NULL
RNA	NULL
.	NULL

We	NULL
investigated	NULL
the	NULL
effect	NULL
of	NULL
these	NULL
internal	NULL
Met	NULL
codon	NULL
mutations	NULL
in	NULL
the	NULL
rex	NULL
gene	NULL
on	NULL
viral	NULL
RNA	NULL
expression	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
the	NULL
stable	NULL
transfectants	NULL
and	NULL
subjected	NULL
to	NULL
S1	NULL
nuclease	NULL
analysis	NULL
by	NULL
using	NULL
a	NULL
90-nt	NULL
oligonucleotide	NULL
probe	NULL
spanning	NULL
the	NULL
transcription	NULL
start	NULL
(	NULL
cap	NULL
)	NULL
site	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
correctly	NULL
initiate	NULL
HTLV-II	NULL
mRNA	NULL
results	NULL
in	NULL
protection	NULL
of	NULL
a	NULL
70-nt	NULL
band	NULL
.	NULL

A	NULL
70-nt	NULL
band	NULL
of	NULL
approximately	NULL
equal	NULL
intensities	NULL
was	NULL
protectec	NULL
in	NULL
729pH6neo	NULL
,	NULL
729pH6neoM1	NULL
,	NULL
729pH6neoM2	NULL
,	NULL
and	NULL
729pHt	NULL
neoM	NULL
}	NULL
3	NULL
stable	NULL
transfectant	NULL
RNA	NULL
,	NULL
whereas	NULL
this	NULL
band	NULL
was	NULL
nol	NULL
present	NULL
in	NULL
729pH6neo-SA	NULL
RNA	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

These	NULL
results	NULL
are	NULL
4918	NULL
GREEN	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
J.	NULL
Viror	NULL
.	NULL

wee	NULL
mes	NULL
.	NULL

ame	NULL
sos	NULL
.	NULL

comes	NULL
dit	NULL
Adh	NULL
«	NULL
4-	NULL
<	NULL
4-	NULL
muni	NULL
:	NULL
a	NULL
»	NULL
rooms	NULL
:	NULL
:	NULL
lits	NULL
uae	NULL
P	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Immunoprecipitation	NULL
of	NULL
[	NULL
**S	NULL
)	NULL
methionine-cysteine-labeled	NULL
stable	NULL
transfectant	NULL
cell	NULL
lines	NULL
.	NULL

Cells	NULL
were	NULL
metabolically	NULL
labeled	NULL
,	NULL
and	NULL
cell	NULL
lysates	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

(	NULL
A	NULL
)	NULL
729	NULL
stable	NULL
transfectant	NULL
cell	NULL
lysate	NULL
,	NULL
as	NULL
labeled	NULL
,	NULL
was	NULL
immunoprecipitated	NULL
with	NULL
HTLV-II	NULL
patient	NULL
antisera	NULL
.	NULL

(	NULL
B	NULL
)	NULL
729	NULL
stable	NULL
transfected	NULL
cell	NULL
lysates	NULL
,	NULL
as	NULL
labeled	NULL
,	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
antisera	NULL
directed	NULL
against	NULL
the	NULL
COOH	NULL
terminus	NULL
of	NULL
the	NULL
rex	NULL
gene	NULL
products	NULL
.	NULL

'*C-labeled	NULL
protein	NULL
markers	NULL
were	NULL
purchased	NULL
from	NULL
Amersham	NULL
Corp.	NULL
,	NULL
and	NULL
sizes	NULL
are	NULL
listed	NULL
.	NULL

consistent	NULL
with	NULL
the	NULL
CAT	NULL
assay	NULL
data	NULL
presented	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

S1	NULL
nuclease	NULL
analysis	NULL
of	NULL
tax/rex	NULL
doubly	NULL
spliced	NULL
mRNA	NULL
revealed	NULL
similar	NULL
results	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
Met	NULL
to	NULL
Thr	NULL
mutations	NULL
within	NULL
the	NULL
Rex	NULL
protein	NULL
do	NULL
not	NULL
have	NULL
an	NULL
effect	NULL
on	NULL
transcription	NULL
of	NULL
viral	NULL
RNA	NULL
.	NULL

Viral	NULL
proteins	NULL
expressed	NULL
by	NULL
Rex	NULL
Met	NULL
mutants	NULL
.	NULL

The	NULL
stable	NULL
transfectants	NULL
were	NULL
metabolically	NULL
labeled	NULL
with	NULL
[	NULL
**SJmethio-nine-cysteine	NULL
,	NULL
and	NULL
immunoprecipitations	NULL
were	NULL
performed	NULL
on	NULL
cell	NULL
lysates	NULL
to	NULL
determine	NULL
which	NULL
viral	NULL
proteins	NULL
were	NULL
being	NULL
produced	NULL
.	NULL

Previous	NULL
studies	NULL
indicated	NULL
that	NULL
selective	NULL
point	NULL
mutations	NULL
or	NULL
amino-terminal	NULL
truncation	NULL
of	NULL
the	NULL
rex	NULL
gene	NULL
resulted	NULL
in	NULL
the	NULL
loss	NULL
of	NULL
Gag	NULL
and	NULL
Env	NULL
protein	NULL
expression	NULL
and	NULL
,	NULL
thus	NULL
,	NULL
loss	NULL
of	NULL
production	NULL
and	NULL
release	NULL
of	NULL
infectious	NULL
virions	NULL
.	NULL

Immunoprecipitation	NULL
of	NULL
cell	NULL
lysates	NULL
with	NULL
HTLV-II	NULL
patient	NULL
antisera	NULL
followed	NULL
by	NULL
sodium	NULL
dodecyl	NULL
sulfate-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
and	NULL
autoradiography	NULL
indicated	NULL
that	NULL
the	NULL
stable	NULL
transfectants	NULL
containing	NULL
the	NULL
rex	NULL
internal	NULL
Met	NULL
codon	NULL
mutations	NULL
all	NULL
produced	NULL
significant	NULL
levels	NULL
of	NULL
Gag	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

In	NULL
this	NULL
particular	NULL
experiment	NULL
,	NULL
729pH6neoM3	NULL
appeared	NULL
to	NULL
produce	NULL
more	NULL
Gag	NULL
and	NULL
729pH6neoM1	NULL
produced	NULL
less	NULL
Gag	NULL
than	NULL
the	NULL
wild	NULL
type	NULL
;	NULL
however	NULL
,	NULL
this	NULL
variation	NULL
was	NULL
not	NULL
reproducible	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
rex	NULL
internal	NULL
Met	NULL
codon	NULL
mutants	NULL
are	NULL
all	NULL
functional	NULL
and	NULL
allow	NULL
Gag	NULL
protein	NULL
to	NULL
be	NULL
produced	NULL
.	NULL

To	NULL
determine	NULL
which	NULL
rex	NULL
gene	NULL
products	NULL
were	NULL
being	NULL
produced	NULL
in	NULL
the	NULL
stable	NULL
transfectants	NULL
,	NULL
cell	NULL
lysates	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
antisera	NULL
which	NULL
recognize	NULL
the	NULL
carboxy	NULL
terminus	NULL
of	NULL
Rex	NULL
and	NULL
detect	NULL
both	NULL
Rex	NULL
proteins	NULL
(	NULL
p26'*	NULL
and	NULL
p24	NULL
``	NULL
)	NULL
.	NULL

Both	NULL
p26	NULL
``	NULL
and	NULL
are	NULL
produced	NULL
in	NULL
729pH6neoM1	NULL
,	NULL
729pH6neoM2	NULL
,	NULL
and	NULL
729pHGneoM3	NULL
,	NULL
and	NULL
the	NULL
levels	NULL
of	NULL
these	NULL
proteins	NULL
are	NULL
comparable	NULL
to	NULL
those	NULL
of	NULL
the	NULL
wild-type	NULL
729pHG6Gneo	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
internal	NULL
methionines	NULL
of	NULL
the	NULL
Rex	NULL
protein	NULL
are	NULL
not	NULL
important	NULL
for	NULL
the	NULL
functions	NULL
of	NULL
Rex	NULL
identified	NULL
to	NULL
date	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
smaller	NULL
rex	NULL
gene	NULL
product	NULL
of	NULL
HTLV-II	NULL
,	NULL
p24	NULL
``	NULL
,	NULL
is	NULL
not	NULL
initiated	NULL
at	NULL
one	NULL
of	NULL
the	NULL
internal	NULL
Met	NULL
codons	NULL
.	NULL

Production	NULL
of	NULL
infectious	NULL
virus	NULL
and	NULL
transformation	NULL
.	NULL

We	NULL
determined	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
rex	NULL
Met	NULL
codon	NULL
mutations	NULL
on	NULL
virus	NULL
production	NULL
,	NULL
replication	NULL
,	NULL
and	NULL
transformation	NULL
.	NULL

The	NULL
supernatant	NULL
of	NULL
the	NULL
stable	NULL
transfectants	NULL
was	NULL
assayed	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
virus	NULL
by	NULL
measuring	NULL
in	NULL
vitro	NULL
reverse	NULL
transcriptase	NULL
activity	NULL
.	NULL

Reverse	NULL
transcriptase	NULL
activity	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
supernatant	NULL
of	NULL
all	NULL
stable	NULL
transfectants	NULL
,	NULL
and	NULL
the	NULL
activity	NULL
did	NULL
not	NULL
differ	NULL
by	NULL
more	NULL
than	NULL
twofold	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
stable	NULL
rex	NULL
Met	NULL
codon	NULL
mutant	NULL
transfectants	NULL
release	NULL
virus	NULL
into	NULL
the	NULL
culture	NULL
supernatant	NULL
at	NULL
levels	NULL
similar	NULL
to	NULL
those	NULL
of	NULL
the	NULL
wild-type	NULL
transfectants	NULL
.	NULL

To	NULL
further	NULL
demonstrate	NULL
that	NULL
the	NULL
rex	NULL
internal	NULL
Met	NULL
codon	NULL
mutant	NULL
viruses	NULL
were	NULL
capable	NULL
of	NULL
a	NULL
productive	NULL
infection	NULL
,	NULL
the	NULL
stable	NULL
transfectants	NULL
were	NULL
cocultured	NULL
with	NULL
the	NULL
BJAB	NULL
cell	NULL
line	NULL
.	NULL

BJAB	NULL
cells	NULL
were	NULL
used	NULL
,	NULL
since	NULL
upon	NULL
infection	NULL
by	NULL
HTLV-II	NULL
,	NULL
a	NULL
rapid	NULL
induction	NULL
of	NULL
syncytia	NULL
with	NULL
some	NULL
cytopathicity	NULL
results	NULL
.	NULL

Coculture	NULL
of	NULL
the	NULL
729	NULL
rex	NULL
Met	NULL
codon	NULL
mutant	NULL
transfectants	NULL
with	NULL
BJAB	NULL
cells	NULL
resulted	NULL
in	NULL
syncytium	NULL
formation	NULL
with	NULL
the	NULL
same	NULL
efficiency	NULL
as	NULL
729pH6neo	NULL
,	NULL
and	NULL
syncytia	NULL
could	NULL
be	NULL
induced	NULL
with	NULL
as	NULL
few	NULL
as	NULL
10	NULL
irradiated	NULL
producer	NULL
cells	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
729	NULL
rex	NULL
Met	NULL
codon	NULL
mutants	NULL
(	NULL
M1	NULL
,	NULL
M2	NULL
,	NULL
M3	NULL
)	NULL
are	NULL
producing	NULL
infectious	NULL
virus	NULL
.	NULL

Following	NULL
coculture	NULL
of	NULL
the	NULL
producer	NULL
cells	NULL
with	NULL
the	NULL
BJAB	NULL
cells	NULL
,	NULL
the	NULL
cultures	NULL
were	NULL
maintained	NULL
for	NULL
3	NULL
weeks	NULL
by	NULL
adding	NULL
fresh	NULL
BJAB	NULL
Vor	NULL
.	NULL

64	NULL
,	NULL
1990	NULL
TABLE	NULL
2	NULL
.	NULL

Infection	NULL
of	NULL
cells	NULL
Stable	NULL
BJAB®	NULL
Primary	NULL
T-cell	NULL
Immunofiuores-	NULL
transfectants	NULL
``	NULL
transformation	NULL
cence	NULL
p19	NULL
Gag	NULL
729	NULL
-	NULL
-	NULL
729pH6neo	NULL
+	NULL
(	NULL
10	NULL
)	NULL
+	NULL
+	NULL
729pH6neo-SA	NULL
-	NULL
-	NULL
729pH6neo-UT	NULL
+	NULL
(	NULL
10	NULL
)	NULL
+	NULL
+	NULL
729pH6neoM1	NULL
+	NULL
(	NULL
10	NULL
)	NULL
+	NULL
+	NULL
729pH6neoM2	NULL
+	NULL
(	NULL
{	NULL
10	NULL
)	NULL
+	NULL
+	NULL
729pH6neoM3	NULL
+	NULL
(	NULL
10	NULL
)	NULL
+	NULL
+	NULL
``	NULL
729	NULL
stably	NULL
transfected	NULL
cells	NULL
were	NULL
irradiated	NULL
with	NULL
10,000	NULL
rads	NULL
,	NULL
and	NULL
10°	NULL
cells	NULL
were	NULL
cocultured	NULL
with	NULL
5	NULL
x	NULL
10°	NULL
stimulated	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
,	NULL
or	NULL
serial	NULL
10-fold	NULL
dilutions	NULL
of	NULL
irradiated	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
10°	NULL
BJAB	NULL
cells	NULL
in	NULL
24-well	NULL
culture	NULL
plates	NULL
.	NULL

Cells	NULL
were	NULL
fed	NULL
twice	NULL
a	NULL
week	NULL
with	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
and	NULL
antibiotics	NULL
.	NULL

Syncytia	NULL
were	NULL
scored	NULL
microscopically	NULL
3	NULL
to	NULL
7	NULL
days	NULL
postplating	NULL
.	NULL

Transformed	NULL
cells	NULL
grew	NULL
out	NULL
3	NULL
to	NULL
4	NULL
weeks	NULL
postplating	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
HTLV	NULL
was	NULL
confirmed	NULL
by	NULL
detection	NULL
of	NULL
HTLV	NULL
p19	NULL
Gag	NULL
by	NULL
immunofluorescence	NULL
in	NULL
both	NULL
cases	NULL
.	NULL

*	NULL
Numbers	NULL
in	NULL
parentheses	NULL
indicate	NULL
the	NULL
minimum	NULL
number	NULL
of	NULL
729	NULL
producer	NULL
cells	NULL
required	NULL
for	NULL
syncytium	NULL
induction	NULL
following	NULL
coculture	NULL
with	NULL
BJAB	NULL
cells	NULL
.	NULL

cells	NULL
once	NULL
a	NULL
week	NULL
to	NULL
compensate	NULL
for	NULL
the	NULL
loss	NULL
of	NULL
the	NULL
cells	NULL
due	NULL
to	NULL
syncytium	NULL
formation	NULL
and	NULL
cytopathicity	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
HTLV-II	NULL
proviral	NULL
DNA	NULL
was	NULL
present	NULL
in	NULL
the	NULL
BJAB	NULL
cells	NULL
cocultured	NULL
with	NULL
the	NULL
729	NULL
transfectants	NULL
,	NULL
cell	NULL
DNA	NULL
was	NULL
analyzed	NULL
by	NULL
nucleic	NULL
acid	NULL
hybridization	NULL
following	NULL
digestion	NULL
with	NULL
diagnostic	NULL
restriction	NULL
endonucleases	NULL
(	NULL
BamHI	NULL
,	NULL
Clal	NULL
,	NULL
and	NULL
Milul	NULL
)	NULL
.	NULL

All	NULL
stable	NULL
BJAB	NULL
cocultures	NULL
positive	NULL
for	NULL
syncytium	NULL
formation	NULL
contained	NULL
HTLV-II	NULL
proviral	NULL
DNA	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

It	NULL
was	NULL
also	NULL
important	NULL
to	NULL
confirm	NULL
the	NULL
stability	NULL
of	NULL
the	NULL
rex	NULL
Met	NULL
codon	NULL
mutations	NULL
in	NULL
the	NULL
BJAB-infected	NULL
culture	NULL
and	NULL
to	NULL
ascertain	NULL
whether	NULL
these	NULL
mutations	NULL
reverted	NULL
in	NULL
culture	NULL
.	NULL

The	NULL
M3	NULL
mutation	NULL
,	NULL
which	NULL
eliminated	NULL
the	NULL
Clal	NULL
restriction	NULL
site	NULL
,	NULL
was	NULL
still	NULL
present	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
the	NULL
inability	NULL
of	NULL
Clal	NULL
to	NULL
digest	NULL
HTLV-II	NULL
M3-infected	NULL
BJAB	NULL
high-molecular-weight	NULL
DNA	NULL
.	NULL

The	NULL
M1	NULL
and	NULL
M2	NULL
mutations	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
M3	NULL
Met	NULL
a	NULL
#	NULL
#	NULL
~	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

Southern	NULL
hybridization	NULL
analysis	NULL
of	NULL
BJAB-infected	NULL
cell	NULL
DNA	NULL
.	NULL

Ten	NULL
micrograms	NULL
of	NULL
high-	NULL
molecular-weight	NULL
cell	NULL
DNA	NULL
,	NULL
as	NULL
labeled	NULL
,	NULL
was	NULL
double	NULL
digested	NULL
with	NULL
BamHI	NULL
and	NULL
Clal	NULL
or	NULL
with	NULL
BamHI	NULL
and	NULL
Mlul	NULL
(	NULL
indicated	NULL
by	NULL
an	NULL
asterisk	NULL
)	NULL
,	NULL
electrophoresed	NULL
through	NULL
a	NULL
0.7	NULL
%	NULL
agarose	NULL
gel	NULL
,	NULL
blotted	NULL
to	NULL
nitrocellulose	NULL
paper	NULL
,	NULL
and	NULL
hybridized	NULL
to	NULL
a	NULL
P-labeled	NULL
,	NULL
HTLV-II-specific	NULL
1,176-bp	NULL
probe	NULL
(	NULL
Xhol	NULL
[	NULL
nt	NULL
6209	NULL
]	NULL
-Clal	NULL
[	NULL
nt	NULL
7384	NULL
]	NULL
)	NULL
.	NULL

The	NULL
labeled	NULL
arrows	NULL
,	NULL
in	NULL
base	NULL
pairs	NULL
,	NULL
indicate	NULL
expected	NULL
HTLV-II-specific	NULL
fragments	NULL
and	NULL
were	NULL
determined	NULL
by	NULL
comparison	NULL
with	NULL
HindIII	NULL
digests	NULL
of	NULL
lambda	NULL
and	NULL
SV40	NULL
DNAs	NULL
.	NULL

HTLV-II	NULL
rex	NULL
GENE	NULL
4919	NULL
mutations	NULL
,	NULL
were	NULL
confirmed	NULL
by	NULL
direct	NULL
sequencing	NULL
of	NULL
polymerase	NULL
chain	NULL
reaction-amplified	NULL
products	NULL
of	NULL
BJAB	NULL
coculture	NULL
DNA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
the	NULL
rex	NULL
internal	NULL
Met	NULL
codon	NULL
mutant	NULL
viruses	NULL
are	NULL
stable	NULL
and	NULL
infectious	NULL
in	NULL
BJAB	NULL
cells	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
rex	NULL
Met	NULL
codon	NULL
mutations	NULL
altered	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
virus	NULL
to	NULL
transform	NULL
primary	NULL
T	NULL
cells	NULL
,	NULL
irradiated	NULL
729	NULL
producer	NULL
cells	NULL
were	NULL
cocultured	NULL
with	NULL
primary	NULL
T	NULL
lymphocytes	NULL
.	NULL

Three	NULL
to	NULL
four	NULL
weeks	NULL
following	NULL
coculture	NULL
,	NULL
stable	NULL
transformed	NULL
T	NULL
cells	NULL
grew	NULL
out	NULL
for	NULL
all	NULL
rex	NULL
internal	NULL
Met	NULL
codon	NULL
mutants	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

These	NULL
results	NULL
further	NULL
confirm	NULL
that	NULL
the	NULL
internal	NULL
methionines	NULL
of	NULL
the	NULL
Rex	NULL
protein	NULL
are	NULL
not	NULL
crucial	NULL
to	NULL
the	NULL
overall	NULL
function	NULL
of	NULL
Rex	NULL
,	NULL
and	NULL
their	NULL
loss	NULL
does	NULL
not	NULL
hinder	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
virus	NULL
to	NULL
productively	NULL
infect	NULL
or	NULL
transform	NULL
primary	NULL
T	NULL
cells	NULL
in	NULL
vitro	NULL
.	NULL

DISCUSSION	NULL
We	NULL
systematically	NULL
mutated	NULL
the	NULL
Met	NULL
codons	NULL
of	NULL
the	NULL
HTLV-II	NULL
rex	NULL
gene	NULL
to	NULL
determine	NULL
their	NULL
importance	NULL
for	NULL
Rex	NULL
protein	NULL
production	NULL
and	NULL
function	NULL
in	NULL
relation	NULL
to	NULL
viral	NULL
gene	NULL
expression	NULL
and	NULL
transformation	NULL
.	NULL

We	NULL
confirmed	NULL
that	NULL
only	NULL
the	NULL
first	NULL
Met	NULL
codon	NULL
is	NULL
required	NULL
for	NULL
Rex	NULL
regulatory	NULL
function	NULL
and	NULL
that	NULL
mutation	NULL
of	NULL
the	NULL
internal	NULL
Met	NULL
codons	NULL
did	NULL
not	NULL
alter	NULL
this	NULL
function	NULL
.	NULL

These	NULL
results	NULL
also	NULL
indicate	NULL
that	NULL
p24	NULL
'	NULL
``	NULL
**	NULL
translation	NULL
is	NULL
not	NULL
initiated	NULL
at	NULL
a	NULL
Met	NULL
codon	NULL
downstream	NULL
of	NULL
the	NULL
initiation	NULL
of	NULL
p26rex	NULL
.	NULL

The	NULL
results	NULL
presented	NULL
in	NULL
this	NULL
report	NULL
,	NULL
which	NULL
investigated	NULL
only	NULL
HTLV-II	NULL
Rex	NULL
production	NULL
and	NULL
function	NULL
,	NULL
are	NULL
in	NULL
apparent	NULL
conflict	NULL
with	NULL
earlier	NULL
studies	NULL
investigating	NULL
Rex	NULL
protein	NULL
initiation	NULL
in	NULL
HTLV-I	NULL
.	NULL

Those	NULL
experiments	NULL
identified	NULL
the	NULL
initiation	NULL
sites	NULL
for	NULL
the	NULL
p27	NULL
``	NULL
**	NULL
and	NULL
p21	NULL
'	NULL
``	NULL
``	NULL
*	NULL
proteins	NULL
and	NULL
determined	NULL
that	NULL
p21	NULL
*	NULL
was	NULL
initiated	NULL
at	NULL
an	NULL
internal	NULL
Met	NULL
codon	NULL
(	NULL
29	NULL
)	NULL
.	NULL

This	NULL
Met	NULL
codon	NULL
,	NULL
which	NULL
is	NULL
conserved	NULL
between	NULL
HTLV-I	NULL
and	NULL
HTLV-II	NULL
,	NULL
corresponds	NULL
to	NULL
M3	NULL
in	NULL
our	NULL
studies	NULL
and	NULL
did	NULL
not	NULL
affect	NULL
HTLV-II	NULL
p24'**	NULL
production	NULL
.	NULL

Two	NULL
possibilities	NULL
might	NULL
explain	NULL
the	NULL
dis-crepancy	NULL
.	NULL

The	NULL
first	NULL
interpretation	NULL
is	NULL
that	NULL
production	NULL
of	NULL
the	NULL
Rex	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
differs	NULL
with	NULL
respect	NULL
to	NULL
HTLV-I	NULL
and	NULL
HTLV-II	NULL
.	NULL

The	NULL
second	NULL
possibility	NULL
is	NULL
that	NULL
the	NULL
HTLV-I	NULL
results	NULL
may	NULL
be	NULL
an	NULL
artifact	NULL
of	NULL
the	NULL
experimental	NULL
system	NULL
,	NULL
since	NULL
conclusions	NULL
were	NULL
based	NULL
on	NULL
analysis	NULL
of	NULL
in	NULL
vitro-synthesized	NULL
RNA	NULL
,	NULL
followed	NULL
by	NULL
translation	NULL
of	NULL
this	NULL
RNA	NULL
in	NULL
a	NULL
rabbit	NULL
reticulocyte	NULL
lysate	NULL
.	NULL

Those	NULL
viral	NULL
constructs	NULL
have	NULL
not	NULL
been	NULL
tested	NULL
directly	NULL
in	NULL
cells	NULL
either	NULL
by	NULL
transfection	NULL
or	NULL
infection	NULL
.	NULL

Bovine	NULL
leukosis	NULL
virus	NULL
contains	NULL
a	NULL
gene	NULL
analogous	NULL
to	NULL
rex	NULL
,	NULL
which	NULL
also	NULL
codes	NULL
for	NULL
two	NULL
gene	NULL
products	NULL
(	NULL
35	NULL
)	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
the	NULL
smaller	NULL
rex	NULL
gene	NULL
product	NULL
is	NULL
conserved	NULL
between	NULL
HTLV-I	NULL
,	NULL
HTLV-II	NULL
,	NULL
and	NULL
bovine	NULL
leukosis	NULL
virus	NULL
suggests	NULL
that	NULL
this	NULL
gene	NULL
product	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
the	NULL
viral	NULL
life-cycle	NULL
and	NULL
possibly	NULL
has	NULL
a	NULL
function	NULL
distinct	NULL
from	NULL
the	NULL
larger	NULL
protein	NULL
.	NULL

One	NULL
function	NULL
of	NULL
Rex	NULL
,	NULL
which	NULL
has	NULL
been	NULL
clearly	NULL
defined	NULL
,	NULL
involves	NULL
its	NULL
ability	NULL
to	NULL
facilitate	NULL
the	NULL
transport	NULL
of	NULL
unspliced	NULL
gag/pol	NULL
mRNA	NULL
and	NULL
singly	NULL
spliced	NULL
env	NULL
mRNA	NULL
from	NULL
the	NULL
nucleus	NULL
to	NULL
the	NULL
cytoplasm	NULL
,	NULL
resulting	NULL
in	NULL
increased	NULL
Gag	NULL
and	NULL
Env	NULL
protein	NULL
production	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
first	NULL
rex	NULL
ATG	NULL
initiation	NULL
codon	NULL
(	NULL
p27	NULL
'	NULL
``	NULL
``	NULL
*	NULL
``	NULL
/	NULL
p26	NULL
``	NULL
)	NULL
results	NULL
in	NULL
protein	NULL
loss	NULL
and	NULL
function	NULL
(	NULL
20	NULL
,	NULL
37	NULL
)	NULL
.	NULL

There	NULL
is	NULL
also	NULL
evidence	NULL
that	NULL
Rex	NULL
has	NULL
a	NULL
secondary	NULL
function	NULL
in	NULL
HTLV-II	NULL
gene	NULL
expression	NULL
.	NULL

At	NULL
high	NULL
concentrations	NULL
,	NULL
Rex	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
down	NULL
regulate	NULL
or	NULL
inhibit	NULL
Tax-mediated	NULL
trans	NULL
activation	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
first	NULL
rex	NULL
ATG	NULL
codon	NULL
also	NULL
results	NULL
in	NULL
loss	NULL
of	NULL
this	NULL
effect	NULL
(	NULL
37	NULL
)	NULL
.	NULL

These	NULL
experiments	NULL
have	NULL
not	NULL
addressed	NULL
the	NULL
potential	NULL
role	NULL
which	NULL
the	NULL
smaller	NULL
rex	NULL
gene	NULL
product	NULL
plays	NULL
in	NULL
overall	NULL
Rex	NULL
regulation	NULL
of	NULL
viral	NULL
gene	NULL
expression	NULL
.	NULL

Our	NULL
results	NULL
demonstrate	NULL
that	NULL
p24	NULL
'	NULL
``	NULL
**	NULL
is	NULL
not	NULL
initiated	NULL
at	NULL
an	NULL
internal	NULL
Met	NULL
codon	NULL
.	NULL

Two	NULL
possibilities	NULL
that	NULL
could	NULL
account	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
both	NULL
p26	NULL
``	NULL
*	NULL
and	NULL
p24'**	NULL
involve	NULL
posttransla-	NULL
4920	NULL
GREEN	NULL
ET	NULL
AL	NULL
.	NULL

tional	NULL
modification	NULL
.	NULL

First	NULL
,	NULL
p26'*	NULL
and	NULL
p24	NULL
'	NULL
``	NULL
*	NULL
may	NULL
have	NULL
the	NULL
same	NULL
amino	NULL
acid	NULL
composition	NULL
or	NULL
backbone	NULL
and	NULL
the	NULL
appearance	NULL
of	NULL
p26	NULL
*	NULL
is	NULL
due	NULL
to	NULL
glycosylation	NULL
or	NULL
phosphorylation	NULL
.	NULL

The	NULL
second	NULL
possibility	NULL
is	NULL
that	NULL
p24'*	NULL
is	NULL
a	NULL
degradation	NULL
or	NULL
cleavage	NULL
product	NULL
of	NULL
p26	NULL
``	NULL
*	NULL
.	NULL

However	NULL
,	NULL
our	NULL
preliminary	NULL
investigations	NULL
indicate	NULL
that	NULL
p24	NULL
``	NULL
**	NULL
is	NULL
not	NULL
derived	NULL
from	NULL
p26	NULL
``	NULL
via	NULL
proteolysis	NULL
.	NULL

Further	NULL
analysis	NULL
of	NULL
the	NULL
rex	NULL
gene	NULL
will	NULL
be	NULL
required	NULL
to	NULL
precisely	NULL
determine	NULL
the	NULL
relationship	NULL
between	NULL
p26'*	NULL
and	NULL
p24	NULL
'	NULL
``	NULL
*	NULL
.	NULL

Once	NULL
this	NULL
is	NULL
determined	NULL
,	NULL
one	NULL
can	NULL
address	NULL
whether	NULL
these	NULL
proteins	NULL
are	NULL
functionally	NULL
distinct	NULL
by	NULL
further	NULL
mutational	NULL
analysis	NULL
of	NULL
the	NULL
rex	NULL
gene	NULL
and	NULL
insertion	NULL
into	NULL
the	NULL
HTLV-II	NULL
infectious	NULL
proviral	NULL
clone	NULL
.	NULL

This	NULL
will	NULL
ultimately	NULL
be	NULL
beneficial	NULL
to	NULL
understanding	NULL
the	NULL
regulation	NULL
of	NULL
HTLV	NULL
gene	NULL
expression	NULL
and	NULL
its	NULL
role	NULL
in	NULL
disease	NULL
development	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
laboratory	NULL
members	NULL
S.	NULL
Arrigo	NULL
,	NULL
J.	NULL
Zack	NULL
,	NULL
M.	NULL
Yip	NULL
,	NULL
W.	NULL
O'Brien	NULL
,	NULL
G.	NULL
Feuer	NULL
,	NULL
and	NULL
D.	NULL
Camerini	NULL
for	NULL
editorial	NULL
comments	NULL
and	NULL
W.	NULL
Aft	NULL
for	NULL
preparation	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
American	NULL
Cancer	NULL
Society	NULL
grant	NULL
PF-3369	NULL
,	NULL
a	NULL
Leukemia	NULL
Society	NULL
grant	NULL
,	NULL
and	NULL
Public	NULL
Health	NULL
Service	NULL
grants	NULL
CA	NULL
38597	NULL
and	NULL
CA	NULL
32737	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
.	NULL

P.L.G	NULL
.	NULL

is	NULL
an	NULL
American	NULL
Cancer	NULL
Society	NULL
Fellow	NULL
.	NULL

LITERATURE	NULL
CITED	NULL
1	NULL
.	NULL

Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
E.	NULL
Bohnlein	NULL
,	NULL
J.	NULL
W.	NULL
Lowenthal	NULL
,	NULL
Y.	NULL
Wano	NULL
,	NULL
B.	NULL
R.	NULL
Franza	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1988	NULL
.	NULL

HTLV-I	NULL
tax	NULL
induces	NULL
cellular	NULL
proteins	NULL
that	NULL
activate	NULL
the	NULL
kB	NULL
element	NULL
in	NULL
the	NULL
IL-2	NULL
receptor	NULL
a	NULL
gene	NULL
.	NULL

Science	NULL
241:1652-1655	NULL
.	NULL

2	NULL
.	NULL

Berk	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Sharp	NULL
.	NULL

1977	NULL
.	NULL

Sizing	NULL
and	NULL
mapping	NULL
of	NULL
early	NULL
adenovirus	NULL
mRNAs	NULL
by	NULL
gel	NULL
electrophoresis	NULL
of	NULL
S1	NULL
endonuclease-digested	NULL
hybrids	NULL
.	NULL

Cell	NULL
12:721-732	NULL
.	NULL

3	NULL
.	NULL

Cann	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Y.	NULL
Koyanagi	NULL
,	NULL
and	NULL
I.	NULL
S.	NULL
Y.	NULL
Chen	NULL
.	NULL

1988	NULL
.	NULL

High	NULL
efficiency	NULL
transfection	NULL
of	NULL
primary	NULL
human	NULL
lymphocytes	NULL
and	NULL
studies	NULL
of	NULL
gene	NULL
expression	NULL
.	NULL

Oncogene	NULL
3:123-128	NULL
.	NULL

4	NULL
.	NULL

Cann	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
J.	NULL
D.	NULL
Rosenblatt	NULL
,	NULL
W.	NULL
Wachsman	NULL
,	NULL
N.	NULL
P.	NULL
Shah	NULL
,	NULL
and	NULL
I.	NULL
S.	NULL
Y.	NULL
Chen	NULL
.	NULL

1985	NULL
.	NULL

Identification	NULL
of	NULL
the	NULL
gene	NULL
responsible	NULL
for	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
transcriptional	NULL
regulation	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
318:571-574	NULL
.	NULL

5	NULL
.	NULL

Chen	NULL
,	NULL
I.	NULL
S.	NULL
Y.	NULL
,	NULL
A.	NULL
J.	NULL
Cann	NULL
,	NULL
N.	NULL
P.	NULL
Shah	NULL
,	NULL
and	NULL
R.	NULL
B.	NULL
Gaynor	NULL
.	NULL

1985	NULL
.	NULL

Functional	NULL
relationship	NULL
of	NULL
HTLV-II	NULL
x	NULL
and	NULL
adenovirus	NULL
ElA	NULL
proteins	NULL
in	NULL
transcriptional	NULL
activation	NULL
.	NULL

Science	NULL
230:570-573	NULL
.	NULL

6	NULL
.	NULL

Chen	NULL
,	NULL
I	NULL
.	NULL

S	NULL
,	NULL
Y.	NULL
,	NULL
J.	NULL
McLaughlin	NULL
,	NULL
J.	NULL
C.	NULL
Gasson	NULL
,	NULL
S.	NULL
C.	NULL
Clark	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Golde	NULL
.	NULL

1983	NULL
.	NULL

Molecular	NULL
characterization	NULL
of	NULL
genome	NULL
of	NULL
a	NULL
novel	NULL
human	NULL
T-cell	NULL
leukaemia	NULL
virus	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
305:502-505	NULL
.	NULL

7	NULL
.	NULL

Chen	NULL
,	NULL
I.	NULL
S.	NULL
Y.	NULL
,	NULL
S.	NULL
G.	NULL
Quan	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Golde	NULL
.	NULL

1983	NULL
.	NULL

Human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
II	NULL
transforms	NULL
normal	NULL
human	NULL
lymphocytes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
80:7006-7009	NULL
.	NULL

8	NULL
.	NULL

Cross	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
M.	NULL
B.	NULL
Feinberg	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
Wolf	NULL
,	NULL
N.	NULL
J.	NULL
Holbrook	NULL
,	NULL
F.	NULL
Wong-Staal	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1987	NULL
.	NULL

Regulation	NULL
of	NULL
the	NULL
human	NULL
interleukin-2	NULL
receptor	NULL
alpha	NULL
promoter	NULL
:	NULL
activation	NULL
of	NULL
a	NULL
nonfunc-tional	NULL
promoter	NULL
by	NULL
the	NULL
transactivator	NULL
gene	NULL
of	NULL
HTLV-I	NULL
.	NULL

Cell	NULL
49:47-56	NULL
.	NULL

9	NULL
.	NULL

Cullen	NULL
,	NULL
B.	NULL
R.	NULL
1986	NULL
.	NULL

Trans-activation	NULL
of	NULL
human	NULL
immunodefi-ciency	NULL
virus	NULL
occurs	NULL
via	NULL
a	NULL
bimodal	NULL
mechanism	NULL
.	NULL

Cell	NULL
46:973-982	NULL
.	NULL

10	NULL
.	NULL

Fujisawa	NULL
,	NULL
J.	NULL
,	NULL
M.	NULL
Seiki	NULL
,	NULL
T.	NULL
Kiyokawa	NULL
,	NULL
and	NULL
M.	NULL
Yoshida	NULL
.	NULL

1985	NULL
.	NULL

Functional	NULL
activation	NULL
of	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
by	NULL
a	NULL
trans-acting	NULL
factor	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
82:2277-2281	NULL
.	NULL

11	NULL
.	NULL

Gessain	NULL
,	NULL
A.	NULL
,	NULL
J.	NULL
C.	NULL
Vernant	NULL
,	NULL
L.	NULL
Maurs	NULL
,	NULL
F.	NULL
Barin	NULL
,	NULL
O.	NULL
Gout	NULL
,	NULL
A.	NULL
Calender	NULL
,	NULL
and	NULL
G.	NULL
de	NULL
The	NULL
.	NULL

1985	NULL
.	NULL

Antibodies	NULL
to	NULL
human	NULL
T-lymphotropic	NULL
virus	NULL
type-I	NULL
in	NULL
patients	NULL
with	NULL
tropical	NULL
spastic	NULL
paraparesis	NULL
.	NULL

Lancet	NULL
ii:407-409	NULL
.	NULL

12	NULL
.	NULL

Goh	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
J.	NULL
Sodroski	NULL
,	NULL
C.	NULL
Rosen	NULL
,	NULL
M.	NULL
Essex	NULL
,	NULL
and	NULL
W.	NULL
A.	NULL
Haseltine	NULL
.	NULL

1985	NULL
.	NULL

Subcellular	NULL
localization	NULL
of	NULL
the	NULL
product	NULL
of	NULL
the	NULL
long	NULL
open	NULL
reading	NULL
frame	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
.	NULL

Science	NULL
227:1227-1228	NULL
.	NULL

13	NULL
.	NULL

Gorman	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
L.	NULL
F.	NULL
Moffat	NULL
,	NULL
and	NULL
B.	NULL
H.	NULL
Howard	NULL
.	NULL

1982	NULL
.	NULL

Recombinant	NULL
genomes	NULL
which	NULL
express	NULL
chloramphenicol	NULL
acetyl-	NULL
14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

J.	NULL
Viror	NULL
.	NULL

transferase	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

2:1044-1051	NULL
.	NULL

Grassmann	NULL
,	NULL
R.	NULL
,	NULL
C.	NULL
Dengler	NULL
,	NULL
I.	NULL
Muller-Fleckenstein	NULL
,	NULL
B.	NULL
Flecken-stein	NULL
,	NULL
K.	NULL
McGuire	NULL
,	NULL
M.-C.	NULL
Dokhelar	NULL
,	NULL
J.	NULL
G.	NULL
Sodroski	NULL
,	NULL
and	NULL
W.	NULL
A.	NULL
Haseltine	NULL
.	NULL

1989	NULL
.	NULL

Transformation	NULL
to	NULL
continuous	NULL
growth	NULL
of	NULL
primary	NULL
human	NULL
T	NULL
lymphocytes	NULL
by	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
X-region	NULL
genes	NULL
transduced	NULL
by	NULL
a	NULL
Herpesvirus	NULL
saimiri	NULL
vector	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:3351-3355	NULL
.	NULL

Green	NULL
,	NULL
P.	NULL
L.	NULL
,	NULL
D.	NULL
A.	NULL
Kaehler	NULL
,	NULL
L.	NULL
M.	NULL
Bennett	NULL
,	NULL
and	NULL
R.	NULL
Risser	NULL
.	NULL

1989	NULL
.	NULL

Multiple	NULL
steps	NULL
are	NULL
required	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
tumors	NULL
by	NULL
Abelson	NULL
murine	NULL
leukemia	NULL
virus	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63:1989-1994	NULL
.	NULL

Hanly	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
L.	NULL
T.	NULL
Rimsky	NULL
,	NULL
M.	NULL
H.	NULL
Malim	NULL
,	NULL
J.	NULL
H.	NULL
Kim	NULL
,	NULL
J.	NULL
Hauber	NULL
,	NULL
M.	NULL
Duc	NULL
Dudon	NULL
,	NULL
S.-Y	NULL
.	NULL

Le	NULL
,	NULL
J.	NULL
V.	NULL
Maizel	NULL
,	NULL
B.	NULL
R.	NULL
Cullen	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1989	NULL
.	NULL

Comparative	NULL
analysis	NULL
of	NULL
the	NULL
HTLV-I	NULL
Rex	NULL
and	NULL
HIV-1	NULL
Rev	NULL
trans-regulatory	NULL
proteins	NULL
and	NULL
their	NULL
response	NULL
ele-ments	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

3:1534-1544	NULL
.	NULL

Hidaka	NULL
,	NULL
M.	NULL
,	NULL
J.	NULL
Inoue	NULL
,	NULL
M.	NULL
Yoshida	NULL
,	NULL
and	NULL
M.	NULL
Seiki	NULL
.	NULL

1988	NULL
.	NULL

Post	NULL
transcriptional	NULL
regulator	NULL
(	NULL
rex	NULL
)	NULL
of	NULL
HTLV-I	NULL
initiates	NULL
expression	NULL
of	NULL
viral	NULL
structural	NULL
proteins	NULL
but	NULL
suppresses	NULL
expression	NULL
of	NULL
regulatory	NULL
proteins	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

7:519-523	NULL
.	NULL

Hinuma	NULL
,	NULL
Y.	NULL
,	NULL
K.	NULL
Nagata	NULL
,	NULL
M.	NULL
Hanaoka	NULL
,	NULL
M.	NULL
Nakai	NULL
,	NULL
T.	NULL
Matsumoto	NULL
,	NULL
K.-I	NULL
.	NULL

Kinoshita	NULL
,	NULL
S.	NULL
Shirakawa	NULL
,	NULL
and	NULL
I.	NULL
Miyoshi	NULL
.	NULL

1981	NULL
.	NULL

Adult	NULL
T-cell	NULL
leukemia	NULL
:	NULL
antigen	NULL
in	NULL
an	NULL
ATL	NULL
cell	NULL
line	NULL
and	NULL
detection	NULL
of	NULL
antibodies	NULL
to	NULL
the	NULL
antigen	NULL
in	NULL
human	NULL
sera	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
78:6476-6480	NULL
.	NULL

Inoue	NULL
,	NULL
J.	NULL
,	NULL
M.	NULL
Seiki	NULL
,	NULL
T.	NULL
Taniguchi	NULL
,	NULL
S.	NULL
Tsuru	NULL
,	NULL
and	NULL
M.	NULL
Yoshida	NULL
.	NULL

1986	NULL
.	NULL

Induction	NULL
of	NULL
interleukin-2	NULL
receptor	NULL
gene	NULL
by	NULL
p40*	NULL
'	NULL
encoded	NULL
by	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I.	NULL
EMBO	NULL
J	NULL
.	NULL

5:2883-2888	NULL
.	NULL

Inoue	NULL
,	NULL
J.	NULL
,	NULL
M.	NULL
Seiki	NULL
,	NULL
and	NULL
M.	NULL
Yoshida	NULL
.	NULL

1986	NULL
.	NULL

The	NULL
second	NULL
pX	NULL
product	NULL
p27*	NULL
``	NULL
``	NULL
of	NULL
HTLV-I	NULL
is	NULL
required	NULL
for	NULL
gag	NULL
gene	NULL
expression	NULL
.	NULL

FEBS	NULL
Lett	NULL
.	NULL

209:187-190	NULL
.	NULL

Inoue	NULL
,	NULL
J.	NULL
I.	NULL
,	NULL
M.	NULL
Yoshida	NULL
,	NULL
and	NULL
M.	NULL
Seiki	NULL
.	NULL

1987	NULL
.	NULL

Transcriptional	NULL
(	NULL
p40*	NULL
)	NULL
and	NULL
post-transcriptional	NULL
(	NULL
p27*	NULL
``	NULL
``	NULL
)	NULL
regulators	NULL
are	NULL
required	NULL
for	NULL
the	NULL
expression	NULL
and	NULL
replication	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
genes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
84:3653-3657	NULL
.	NULL

Kalyanaraman	NULL
,	NULL
V.	NULL
S.	NULL
,	NULL
M.	NULL
G.	NULL
Sarngadharan	NULL
,	NULL
M.	NULL
Robert-Guroff	NULL
,	NULL
I.	NULL
Miyoshi	NULL
,	NULL
D.	NULL
Blayney	NULL
,	NULL
D.	NULL
Golde	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Gallo	NULL
.	NULL

1892	NULL
.	NULL

A	NULL
new	NULL
subtype	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
(	NULL
HTLV-II	NULL
)	NULL
associated	NULL
with	NULL
a	NULL
T-cell	NULL
variant	NULL
of	NULL
hairy	NULL
cell	NULL
leukemia	NULL
.	NULL

Science	NULL
218:571-573	NULL
.	NULL

Kiyokawa	NULL
,	NULL
T.	NULL
,	NULL
M.	NULL
Seiki	NULL
,	NULL
S.	NULL
Iwashita	NULL
,	NULL
K.	NULL
Imagawa	NULL
,	NULL
F.	NULL
Shimizu	NULL
,	NULL
and	NULL
M.	NULL
Yoshida	NULL
.	NULL

1985.	NULL
p27	NULL
``	NULL
and	NULL
p21	NULL
``	NULL
,	NULL
proteins	NULL
encoded	NULL
by	NULL
the	NULL
pX	NULL
sequence	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I.	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
82:8359-8363	NULL
.	NULL

Kunkel	NULL
,	NULL
T.	NULL
A	NULL
.	NULL

1985	NULL
.	NULL

Rapid	NULL
and	NULL
efficient	NULL
site-specific	NULL
mutagenesis	NULL
without	NULL
phenotypic	NULL
selection	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
82:488-492	NULL
.	NULL

Lee	NULL
,	NULL
H.	NULL
,	NULL
P.	NULL
Swanson	NULL
,	NULL
V.	NULL
S.	NULL
Shorty	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Zack	NULL
,	NULL
J.	NULL
D.	NULL
Rosenblatt	NULL
,	NULL
and	NULL
I.	NULL
S.	NULL
Y.	NULL
Chen	NULL
.	NULL

1989	NULL
.	NULL

High	NULL
rate	NULL
of	NULL
HTLV-II	NULL
infection	NULL
in	NULL
seropositive	NULL
IV	NULL
drug	NULL
abusers	NULL
from	NULL
New	NULL
Orleans	NULL
.	NULL

Science	NULL
244	NULL
:	NULL
471-475	NULL
.	NULL

Maruyama	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
Shibuya	NULL
,	NULL
H.	NULL
Harada	NULL
,	NULL
M.	NULL
Hatakeyama	NULL
,	NULL
M.	NULL
Seiki	NULL
,	NULL
T.	NULL
Fujita	NULL
,	NULL
J.	NULL
Inoue	NULL
,	NULL
M.	NULL
Yoshida	NULL
,	NULL
and	NULL
T.	NULL
Taniguchi	NULL
.	NULL

1987	NULL
.	NULL

Evidence	NULL
for	NULL
aberrant	NULL
activation	NULL
of	NULL
the	NULL
interleukin-2	NULL
autocrine	NULL
loop	NULL
by	NULL
HTLV-I-encoded	NULL
p40	NULL
``	NULL
and	NULL
T3/Ti	NULL
complex	NULL
triggering	NULL
.	NULL

Cell	NULL
48:343-350	NULL
.	NULL

Maxam	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
and	NULL
W.	NULL
Gilbert	NULL
.	NULL

1977	NULL
.	NULL

Sequencing	NULL
end-labeled	NULL
DNA	NULL
with	NULL
base-specific	NULL
chemical	NULL
cleavages	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
74:560-564	NULL
.	NULL

Miwa	NULL
,	NULL
M.	NULL
,	NULL
K.	NULL
Shimotohno	NULL
,	NULL
H.	NULL
Hoshino	NULL
,	NULL
M.	NULL
Fujino	NULL
,	NULL
and	NULL
T.	NULL
Sugimura	NULL
.	NULL

1984	NULL
.	NULL

Detection	NULL
of	NULL
pX	NULL
proteins	NULL
in	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
(	NULL
HTLV	NULL
)	NULL
-infected	NULL
cells	NULL
by	NULL
using	NULL
antibody	NULL
against	NULL
peptide	NULL
deduced	NULL
from	NULL
sequences	NULL
of	NULL
X-IV	NULL
DNA	NULL
of	NULL
HTLV-I	NULL
and	NULL
Xe	NULL
DNA	NULL
of	NULL
HTLV-II	NULL
proviruses	NULL
.	NULL

Gann	NULL
75:752-755	NULL
.	NULL

Nagashima	NULL
,	NULL
K.	NULL
,	NULL
M.	NULL
Yoshida	NULL
,	NULL
and	NULL
M.	NULL
Seiki	NULL
.	NULL

1986	NULL
.	NULL

A	NULL
single	NULL
species	NULL
of	NULL
pX	NULL
mRNA	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
encodes	NULL
trans-activator	NULL
p40	NULL
``	NULL
and	NULL
two	NULL
other	NULL
phosphoproteins	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

60:394-399	NULL
.	NULL

Nerenberg	NULL
,	NULL
M.	NULL
,	NULL
S.	NULL
H.	NULL
Hinrichs	NULL
,	NULL
R.	NULL
K.	NULL
Reynolds	NULL
,	NULL
G.	NULL
Khoury	NULL
,	NULL
and	NULL
G.	NULL
Jay	NULL
.	NULL

1987	NULL
.	NULL

The	NULL
tat	NULL
gene	NULL
of	NULL
human	NULL
T-lymphotropic	NULL
virus	NULL
type	NULL
I	NULL
induces	NULL
mesenchymal	NULL
tumors	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Science	NULL
237:1324-1329	NULL
.	NULL

Nimer	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
J.	NULL
C.	NULL
Gasson	NULL
,	NULL
K.	NULL
Hu	NULL
,	NULL
I.	NULL
Smalberg	NULL
,	NULL
I.	NULL
S.	NULL
Y.	NULL
Chen	NULL
,	NULL
and	NULL
J.	NULL
D.	NULL
Rosenblatt	NULL
.	NULL

1989	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
Vor	NULL
.	NULL

64	NULL
,	NULL
1990	NULL
32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

41	NULL
.	NULL

42.	NULL
by	NULL
HTLV-I	NULL
and	NULL
-II	NULL
tax	NULL
proteins	NULL
.	NULL

Oncogene	NULL
4:671-676	NULL
.	NULL

Osame	NULL
,	NULL
M.	NULL
,	NULL
A.	NULL
Igata	NULL
,	NULL
M.	NULL
Matsumoto	NULL
,	NULL
K.	NULL
Usuku	NULL
,	NULL
S.	NULL
Izumo	NULL
,	NULL
and	NULL
K.	NULL
Kosaka	NULL
.	NULL

1987	NULL
.	NULL

HTLV-I	NULL
associated	NULL
myelopathy	NULL
:	NULL
a	NULL
report	NULL
of	NULL
85	NULL
cases	NULL
.	NULL

Ann	NULL
.	NULL

Neurol	NULL
.	NULL

22:116	NULL
.	NULL

Poiesz	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
F.	NULL
W.	NULL
Ruscetti	NULL
,	NULL
A.	NULL
F.	NULL
Gazdar	NULL
,	NULL
P.	NULL
A.	NULL
Bunn	NULL
,	NULL
J.	NULL
D.	NULL
Minna	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Gallo	NULL
.	NULL

1980	NULL
.	NULL

T-cell	NULL
lines	NULL
established	NULL
from	NULL
human	NULL
T-lymphocytic	NULL
neoplasias	NULL
by	NULL
direct	NULL
response	NULL
to	NULL
T-cell	NULL
growth	NULL
factor	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
77:6815-6819	NULL
.	NULL

Popovic	NULL
,	NULL
M.	NULL
,	NULL
G.	NULL
Lange-Wantzin	NULL
,	NULL
P.	NULL
S.	NULL
Sarin	NULL
,	NULL
D.	NULL
Mann	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Gallo	NULL
.	NULL

1983	NULL
.	NULL

Transformation	NULL
of	NULL
human	NULL
umbilical	NULL
cord	NULL
blood	NULL
T	NULL
cells	NULL
by	NULL
human	NULL
T-cell	NULL
leukemia/lymphoma	NULL
virus	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
80:5402-5406	NULL
.	NULL

Rice	NULL
,	NULL
N.	NULL
R.	NULL
,	NULL
R.	NULL
M.	NULL
Stephens	NULL
,	NULL
D.	NULL
Couez	NULL
,	NULL
J.	NULL
Deschamps	NULL
,	NULL
R.	NULL
Kettmann	NULL
,	NULL
A.	NULL
Burny	NULL
,	NULL
and	NULL
R.	NULL
V.	NULL
Gilden	NULL
.	NULL

1984	NULL
.	NULL

The	NULL
nucleotide	NULL
sequence	NULL
of	NULL
the	NULL
env	NULL
gene	NULL
and	NULL
post-erv	NULL
region	NULL
of	NULL
bovine	NULL
leukemia	NULL
virus	NULL
.	NULL

Virology	NULL
138:82-93	NULL
.	NULL

Robert-Guroff	NULL
,	NULL
M.	NULL
,	NULL
S.	NULL
H.	NULL
Weiss	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Giron	NULL
,	NULL
A.	NULL
M.	NULL
Jennings	NULL
,	NULL
H.	NULL
M.	NULL
Ginzburg	NULL
,	NULL
I	NULL
.	NULL

B.	NULL
Margolis	NULL
,	NULL
W.	NULL
A.	NULL
Blattner	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Gallo	NULL
.	NULL

1986	NULL
.	NULL

Prevalence	NULL
of	NULL
antibodies	NULL
to	NULL
HTLV-I	NULL
,	NULL
-II	NULL
,	NULL
and	NULL
-III	NULL
in	NULL
intravenous	NULL
drug	NULL
abusers	NULL
from	NULL
an	NULL
AIDS	NULL
endemic	NULL
region	NULL
.	NULL

J	NULL
.	NULL

Am	NULL
.	NULL

Med	NULL
.	NULL

Assoc	NULL
.	NULL

255:3133-3137	NULL
.	NULL

Rosenblatt	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
A.	NULL
J.	NULL
Cann	NULL
,	NULL
D.	NULL
J.	NULL
Slamon	NULL
,	NULL
I.	NULL
S.	NULL
Smalberg	NULL
,	NULL
N.	NULL
P.	NULL
Shah	NULL
,	NULL
J.	NULL
Fujii	NULL
,	NULL
W.	NULL
Wachsman	NULL
,	NULL
and	NULL
I.	NULL
S.	NULL
Y.	NULL
Chen	NULL
.	NULL

1988	NULL
.	NULL

HTLV-II	NULL
trans-activation	NULL
is	NULL
regulated	NULL
by	NULL
two	NULL
overlapping	NULL
nonstructural	NULL
genes	NULL
.	NULL

Science	NULL
240:916-919	NULL
.	NULL

Rosenblatt	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
D.	NULL
W.	NULL
Golde	NULL
,	NULL
W.	NULL
Wachsman	NULL
,	NULL
A.	NULL
Jacobs	NULL
,	NULL
G.	NULL
Schmidt	NULL
,	NULL
S.	NULL
Quan	NULL
,	NULL
J.	NULL
C.	NULL
Gasson	NULL
,	NULL
and	NULL
I.	NULL
S.	NULL
Y.	NULL
Chen	NULL
.	NULL

1986	NULL
.	NULL

A	NULL
second	NULL
HTLV-II	NULL
isolate	NULL
associated	NULL
with	NULL
atypical	NULL
hairy-cell	NULL
leukemia	NULL
.	NULL

N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

315:372-375	NULL
.	NULL

Sanger	NULL
,	NULL
F.	NULL
,	NULL
A.	NULL
R.	NULL
Coulson	NULL
,	NULL
B.	NULL
G.	NULL
Barrel	NULL
,	NULL
A.	NULL
G.	NULL
H.	NULL
Smith	NULL
,	NULL
and	NULL
B	NULL
.	NULL

A.	NULL
Roe	NULL
.	NULL

1980	NULL
.	NULL

Cloning	NULL
in	NULL
single	NULL
stranded	NULL
bacteriophage	NULL
as	NULL
an	NULL
aid	NULL
to	NULL
rapid	NULL
DNA	NULL
sequencing	NULL
.	NULL

J.	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

143:161-178.	NULL
.	NULL

Saxon	NULL
,	NULL
A.	NULL
,	NULL
R.	NULL
H.	NULL
Stevens	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Golde	NULL
.	NULL

1978	NULL
.	NULL

T-lymphocyte	NULL
variant	NULL
of	NULL
hairy-cell	NULL
leukemia	NULL
.	NULL

Ann	NULL
.	NULL

Intern	NULL
.	NULL

Med	NULL
.	NULL

88:323-326	NULL
.	NULL

Seiki	NULL
,	NULL
M.	NULL
,	NULL
R.	NULL
Eddy	NULL
,	NULL
T.	NULL
B	NULL
.	NULL

Shows	NULL
,	NULL
and	NULL
M.	NULL
Yoshida	NULL
.	NULL

1984	NULL
.	NULL

Nonspecific	NULL
integration	NULL
of	NULL
the	NULL
HTLV	NULL
provirus	NULL
genome	NULL
into	NULL
adult	NULL
T-cell	NULL
leukaemia	NULL
cells	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
309:640-642	NULL
.	NULL

Seiki	NULL
,	NULL
M.	NULL
,	NULL
S.	NULL
Hattori	NULL
,	NULL
and	NULL
M.	NULL
Yoshida	NULL
.	NULL

1982	NULL
.	NULL

Human	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
:	NULL
molecular	NULL
cloning	NULL
of	NULL
the	NULL
provirus	NULL
DNA	NULL
and	NULL
the	NULL
43	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

HTLV-II	NULL
rex	NULL
GENE	NULL
4921	NULL
unique	NULL
terminal	NULL
structure	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
79:6899-6902	NULL
.	NULL

Seiki	NULL
,	NULL
M.	NULL
,	NULL
J.-I	NULL
.	NULL

Inoue	NULL
,	NULL
T.	NULL
Takeda	NULL
,	NULL
and	NULL
M.	NULL
Yoshida	NULL
.	NULL

1986	NULL
.	NULL

Direct	NULL
evidence	NULL
that	NULL
p40	NULL
``	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
is	NULL
a	NULL
trans-acting	NULL
transcriptional	NULL
activator	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

5:561-565.	NULL
.	NULL

Shima	NULL
,	NULL
H.	NULL
,	NULL
M.	NULL
Takano	NULL
,	NULL
K.	NULL
Shimotohno	NULL
,	NULL
and	NULL
M.	NULL
Miwa	NULL
.	NULL

1986	NULL
.	NULL

Identification	NULL
of	NULL
p26*	NULL
``	NULL
and	NULL
p24*	NULL
``	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
II	NULL
.	NULL

FEBS	NULL
Lett	NULL
.	NULL

209:289-294	NULL
.	NULL

Shimotohno	NULL
,	NULL
K.	NULL
,	NULL
Y.	NULL
Takahashi	NULL
,	NULL
N.	NULL
Shimizu	NULL
,	NULL
T.	NULL
Gojobori	NULL
,	NULL
I.	NULL
S.	NULL
Y.	NULL
Chen	NULL
,	NULL
D.	NULL
W.	NULL
Golde	NULL
,	NULL
M.	NULL
Miwa	NULL
,	NULL
and	NULL
T.	NULL
Sugimura	NULL
.	NULL

1985	NULL
.	NULL

Complete	NULL
nucleotide	NULL
sequence	NULL
of	NULL
an	NULL
infectious	NULL
clone	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
II	NULL
:	NULL
a	NULL
new	NULL
open	NULL
reading	NULL
frame	NULL
for	NULL
the	NULL
protease	NULL
gene	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
82:3101-3105	NULL
.	NULL

Slamon	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
M.	NULL
F.	NULL
Press	NULL
,	NULL
L.	NULL
M.	NULL
Souza	NULL
,	NULL
D.	NULL
C.	NULL
Murdock	NULL
,	NULL
M.	NULL
J.	NULL
Cline	NULL
,	NULL
D.	NULL
W.	NULL
Golde	NULL
,	NULL
J.	NULL
C.	NULL
Gasson	NULL
,	NULL
and	NULL
I.	NULL
S.	NULL
Y.	NULL
Chen	NULL
.	NULL

1985	NULL
.	NULL

Studies	NULL
of	NULL
the	NULL
putative	NULL
transforming	NULL
protein	NULL
of	NULL
the	NULL
type	NULL
I	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
.	NULL

Science	NULL
228:1427-1430	NULL
.	NULL

Southern	NULL
,	NULL
E.	NULL
M.	NULL
1975	NULL
.	NULL

Detection	NULL
of	NULL
specific	NULL
sequences	NULL
among	NULL
DNA	NULL
fragments	NULL
separated	NULL
by	NULL
gel	NULL
electrophoresis	NULL
.	NULL

J.	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

98:503-517	NULL
.	NULL

Tanaka	NULL
,	NULL
A.	NULL
,	NULL
C.	NULL
Takahashi	NULL
,	NULL
S.	NULL
Yamaoka	NULL
,	NULL
T.	NULL
Nosaka	NULL
,	NULL
M.	NULL
Maki	NULL
,	NULL
and	NULL
M.	NULL
Hatanaka	NULL
.	NULL

1990	NULL
.	NULL

Oncogenic	NULL
transformation	NULL
by	NULL
the	NULL
tax	NULL
gene	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
in	NULL
vitro	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:1071-1075	NULL
.	NULL

Tedder	NULL
,	NULL
R.	NULL
S.	NULL
,	NULL
D.	NULL
C.	NULL
Shanson	NULL
,	NULL
D.	NULL
J.	NULL
Jeffries	NULL
,	NULL
R.	NULL
Cheingsong-Popov	NULL
,	NULL
A.	NULL
Dalgleish	NULL
,	NULL
P.	NULL
Clapham	NULL
,	NULL
K.	NULL
Nagy	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Weiss	NULL
.	NULL

1984	NULL
.	NULL

Low	NULL
prevalence	NULL
in	NULL
the	NULL
UK	NULL
of	NULL
HTLV-I	NULL
and	NULL
HTLV-II	NULL
infection	NULL
in	NULL
subjects	NULL
with	NULL
AIDS	NULL
,	NULL
with	NULL
extended	NULL
lymphadenopa-thy	NULL
,	NULL
and	NULL
at	NULL
risk	NULL
of	NULL
AIDS	NULL
.	NULL

Lancet	NULL
ii:125-128	NULL
.	NULL

Yamamoto	NULL
,	NULL
N.	NULL
,	NULL
M.	NULL
Okada	NULL
,	NULL
Y.	NULL
Koyanagi	NULL
,	NULL
Y.	NULL
Kannagi	NULL
,	NULL
M.	NULL
Kannagi	NULL
,	NULL
and	NULL
Y.	NULL
Hinuma	NULL
.	NULL

1982	NULL
.	NULL

Transformation	NULL
of	NULL
human	NULL
leukocytes	NULL
by	NULL
cocultivation	NULL
with	NULL
an	NULL
adult	NULL
T	NULL
cell	NULL
leukemia	NULL
virus	NULL
producer	NULL
cell	NULL
line	NULL
.	NULL

Science	NULL
217:737-739	NULL
.	NULL

Wano	NULL
,	NULL
Y.	NULL
,	NULL
M.	NULL
Feinberg	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
Hosking	NULL
,	NULL
H.	NULL
Bogerd	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1988	NULL
.	NULL

Stable	NULL
expression	NULL
of	NULL
the	NULL
tax	NULL
gene	NULL
of	NULL
type	NULL
I	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
activates	NULL
specific	NULL
cellular	NULL
genes	NULL
involved	NULL
in	NULL
growth	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:9733-9737	NULL
.	NULL

